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ABSTRACT OF THESIS 
EFFECTS OF DIETARY AMINO ACID SUPPLEMENTATION ON MEASURES OF 
WHOLE-BODY AND MUSCLE PROTEIN METABOLISM IN AGED HORSES 
Sarcopenia is a condition that is most common in aged animals, and is characterized by the 
loss of skeletal muscle mass and integrity, and can lead to physical disability and poor 
quality of life. Since skeletal muscle protein synthesis can be limited by the availability of 
amino acids, supplementation of limiting amino acids to ameliorate the progression of 
sarcopenia has become a topic of interest in companion animal research. The objective of 
this study was to examine the effect of amino acid supplementation in aged horses on 
markers of whole body and muscle protein metabolism. In a cross-over design, six old 
horses were studied while receiving each of three treatments in a replicated Latin square 
design. For all three treatments, horses received 1.8% BW/d of timothy hay cubes and 0.5% 
BW/d of experimental concentrate. The three treatments included a control (CON) 
treatment concentrate that was designed to meet all requirements of mature horses when 
fed in combination with the timothy hay cubes, and two supplemented concentrates, 
LYS/THR with additional lysine and threonine (40 mg/kg BW/d and 31 mg/kg BW/d, 
respectively), and LYS/THR/MET with additional lysine, threonine, and methionine (40 
mg/kg BW/d, 31 mg/kg BW/d and 11mg/kg BW/d respectively). In each 15 d period, 
following a 9-day adaptation, horses were fitted with a collection harness, and total urine 
and feces were collected for 72 hours for assessment of nitrogen balance and creatinine 
output. Blood samples were taken directly before feeding and 30, 60, 90, 120, 150, 180, 
210, and 240 minutes post-feeding for analysis of plasma urea nitrogen (PUN), glucose, 
insulin, and plasma amino acid concentrations. Muscle biopsy samples were taken for 
analysis of proteins in the mTOR pathway. Additionally, horses underwent stable isotope 
infusion procedures, and comparisons of phenylalanine kinetics were used to determine 
whole-body rates of protein synthesis and degradation. There was no significant effect of 
treatment on creatinine output (P=0.58), relative abundance of proteins in the mTOR 
pathway (P>0.05), nitrogen retention (P=0.70), or phenylalanine kinetics (P>0.05). PUN 
concentrations were significantly (P=0.0058) higher for LYS/THR and LYS/THR/MET 
than for CON. Atrogin-1 activation was significantly higher for the pre-feeding CON 
sample compared to the post-feeding CON sample. Lack of significant difference in 
creatinine output suggests that there were not significant differences in muscle mass 
between treatments. Lack of significant differences in mTOR protein activation suggests 
that amino acid supplementation did not result in improvements in protein synthesis. Lack 
of significant differences in nitrogen retention and phenylalanine kinetics suggests that 
whole-body protein metabolism was not improved. Additionally, higher PUN 
concentrations in the supplemented diets suggests that the supplemented amino acids being 
provided were catabolized. However, increased activation of Atrogin-1 in the pre-feeding 
CON samples, but not the pre-feeding samples of supplemented treatments, suggests amino 
acid supplementation may have reduced protein degradation in the post-absorptive state. 
Data from the present study suggests that amino acid availability may not have been 
limiting protein synthesis in the sedentary aged horses in the present study.    
Keywords: Equine, aged, supplementation, lysine, threonine, methionine 
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Chapter 1. Introduction 
Sarcopenia is a condition characterized by loss of muscle mass and function, and 
it is most commonly observed in aged animals (Santilli et al., 2014). Loss of skeletal 
muscle integrity associated with sarcopenia can lead to physical disability and poor 
quality of life. Sarcopenia is becoming a pressing issue for many pet owners because 
companion animal lifespans are increasing. The condition results from an imbalance in 
muscle protein synthesis and degradation rates, which ultimately causes a net loss of 
muscle mass.  
Skeletal muscle protein synthetic processes can be limited by the availability of 
amino acids, and can be stimulated by the presence of amino acids. The limiting amino 
acid in an animal’s diet is the essential amino acid that is present in the diet the furthest 
below the animal’s requirement. It is called the limiting amino acid because its deficiency 
limits the amount of protein synthesis that can occur. If the amount of the limiting amino 
acid is increased, the level of protein synthesis can be increased proportionally until the 
amino acid of interest is no longer limiting. Therefore, if this is a primary contributing 
factor, supplementation of suspected limiting amino acids could ameliorate the 
progression of sarcopenia by increasing the availability of limiting amino acids and 
therefore increasing protein synthesis. The topic of amino acid supplementation is of 
particular interest in horses, as relatively little is known about the protein and amino acid 
requirements of horses of any age, and very little is known about the requirements of 
aged horses. Although there is some data to support the idea that amino acid 
supplementation improves maintenance of muscle mass in aged horses (Graham-Thiers 
and Kronfeld, 2005), the cellular mechanisms of that improvement have yet to be 
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elucidated. Therefore, the objective of this research was to examine the effect of amino 
acid supplementation in aged horses on markers of whole body and muscle protein 
metabolism. 
Chapter 2. Literature Review 
Horses older than 20 years of age comprise about 7% of the equine population in 
the United States (Wineland, 1998; APHIS, 2005). However, relatively little is known 
about protein requirements of aged horses. The NRC provides recommendations for 
mature horses in various levels of activity and production (NRC, 2007), but there is no 
adjustment made for the possibility of altered requirements associated with aging. It has 
been postulated in other species that aging may increase the protein requirement, and that 
not meeting that increased requirement could contribute to sarcopenia (Rafii et al., 2015). 
In order to better understand how requirements could be increased in aged animals, this 
literature review will first address basic nutritional principles such as how protein 
digestion and absorption occur and how recommendations for protein intake were 
determined. Additionally, it will review methodological considerations such as the 
benefits and drawbacks of the current methods used to assess protein status and new 
methods and indicators that can be employed. Finally, it will address the signaling 
pathways responsible for muscle anabolism, and how they are affected by age and amino 
acid supplementation.  
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Protein Digestion and Absorption in Horses  
Before proteins can be absorbed and used by the horse, they must be broken down 
to individual amino acids and small peptides. Total tract dietary nitrogen digestibility 
differs between the forage (approximately 60%) and the grain (approximately 95%) 
components of the diet (Gibbs et al., 1988; Farley et al., 1995). Many of the proteins in 
grain products are effectively digested and the resulting amino acids are absorbed in the 
small intestine. However, some proteins present in forage sources are associated with or 
bound by fiber fractions, making them less available for digestion in the small intestine. 
Proteins that are not available for digestion in the small intestine will pass to the cecum 
and large intestine, where microbial fermentation occurs. Data suggests that there is not a 
physiologically significant amount of amino acid absorption from the hindgut 
(McMeniman et al., 1987). However, ammonia form microbial metabolism can be 
absorbed in the hindgut (Bochroder et al., 1994) and can be used for amino acid 
synthesis. 
 In horses, the foregut is the main site of protein digestion. Digestion begins in the 
stomach, where proteins are linearized by hydrochloric acid (HCl). Additionally, HCl 
converts the enzyme pepsinogen to its active form, pepsin. Active pepsin cleaves proteins 
into smaller peptides, and cleaved peptides and proteins then travel to the small intestine. 
In the small intestine, proteins are broken down into smaller peptides by pancreatic 
enzymes and brush border enzymes. Pancreatic peptidases are secreted as an inactive 
zymogen and include trypsinogen, chymotrypsinogen and procarboxypeptidase. 
Trypsinogen is activated by duodenal enteropeptidase, and active trypsin in turn activates 
chymotrypsinogen to chymotrypsin, and procarboxypeptidase to carboxypeptidase. The 
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activated zymogens work to break peptides into smaller chains. Pancreatic enzyme 
digestion of proteins and peptides in the small intestine yields oligopeptides, di- and tri-
peptides and free amino acids. These shortened amino acid chains are further broken 
down by aminopeptidases and endopeptidases at the brush border membrane of the 
jejunum and ileum, and brush border enzymes yield di- and tri-peptides, and free amino 
acids for absorption in the small intestine. Amino acids and small peptides are absorbed 
via a number of transporter systems in the small intestine, and di- and tri-peptides are 
absorbed via the transporter PepT-1 (Figure 2.1). To date there is very little research in 
horses on specific amino  acid transporter systems in horses, although one study 
(Woodward et al., 2010) examined cationic and neutral amino acid transporter transcript 
abundance in the small and large intestine of the horse, and found that cationic and 
neutral amino acid transporters are present at differing levels in the small and large 
intestine, and that while some increase in abundance from cranial to caudal portions of 
the intestine, others decrease, and some remain relatively constant (Woodward et al., 
2010). 
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Figure 2.1 Select amino acid transport systems 
 
Amino acids are absorbed from the lumen across the apical membrane of the intestine via a number of 
transporter systems, including ASC, B0, B0,+ and b0,+. Transporter systems are specific to certain 
combinations of amino acids. In the figure above, each system that can transport a specific amino acid 
across the apical membrane is highlighted in green. Di- and tri-peptides are absorbed from the lumen across 
the apical membrane of the intestine via the transporter PepT-1. Amino acids are transported across the 
basolateral membrane into circulation via a number of transporter systems that are specific to certain 
combinations of amino acids, including A, L, y+ and y+L. In the figure above, each system that can 
transport a specific amino acid across the basolateral membrane is highlighted in blue. 
Figure adapted from Equine Applied and Clinical Nutrition (Urschel and Lawrence, 2013) 
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Proteins associated with feed fractions that are not effectively digested and 
absorbed in the small intestine will pass to the large intestine, where microbial 
fermentation occurs. Here, microbes break down fiber and other nutrients that bypassed 
the small intestine, such as protein and starch. As a by-product, microbes produce a 
number of products including volatile fatty acids, which are absorbed in the large 
intestine. Additionally, some microbes primarily consume proteins and amino acids, and 
in addition to producing volatile fatty acids, also produce ammonia, which can be 
absorbed in the large intestine, and circulate to the liver, where it can be used to produce 
amino acids (Russell, 2002).  
Microbial bodies are a potential source of protein for the horse, as they contain 
amino acids. However, there is currently no literature indicating that absorption of amino 
acids and proteins in the large intestine, either microbial or residual from the small 
intestine, make a significant contribution to meeting protein requirements in horses 
(Reitnour and Salsbury, 1972; McMeniman et al., 1987; Bergen, 2015).  
 
Essential and Limiting Amino Acids in the Equine Diet 
 Essential amino acids are amino acids that must be provided in the diet because 
they are not synthesized by the body in sufficient amounts to meet the requirement.  
There are nine amino acids that are assumed to be essential in the equine diet; histidine, 
isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine 
(Urschel and Lawrence, 2013). Although arginine was classically considered to be 
essential for most animals, some species, such as swine, no longer considered arginine to 
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be essential (NRC, 2012). And although arginine was also once considered an essential 
amino acid in horses (NRC, 2007), contemporary studies have shown that arginine is 
typically only essential in species such as fish, birds and carnivores, or at specific 
developmental stages, such as in neonates, where the demand for arginine for use in 
pathways such as nitrogen excretion are higher than its rate of endogenous synthesis (Ball 
et al., 2007). The limiting amino acid is the essential amino acid that is present in the diet 
the furthest below the animal’s requirement. Because protein synthesis requires a specific 
ratio of amino acids, when an amino acid is not present in sufficient amounts, it limits 
protein synthesis. Therefore, all other amino acids will be in excess of the amount of 
protein synthesis that the limiting amino acid allows and will be catabolized. The first 
limiting amino acid in most common equine diets is lysine (Breuer et al., 1970; Hintz et 
al., 1971a; Potter and Huchton, 1975). The second limiting amino acid has been proposed 
to be threonine (Graham et al., 1994; Staniar et al., 2001). Finally, it has been proposed 
that methionine could potentially be a limiting amino acid in equine diets, although it has 
received comparatively little research (Breuer et al., 1970; Glade and Luba, 1990; 
Winsco et al., 2011). Therefore, supplementation of these individual amino acids has the 
potential to increase the capacity for protein synthesis by increasing the amounts of 
essential amino acids that may be limiting protein synthesis.  
 
Protein Requirements in Horses 
Recommendations for protein intakes for mature sedentary horses are published in 
Nutrient Requirements of Horses (NRC, 2007). The NRC recommends an average of 
1.26g CP/kg BW/d and 4.3 % of CP intake as lysine, which equates to 54 mg/kg BW/d. 
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Currently, the only amino acid requirement that has been specified is lysine. 
Requirements for other amino acids have not been extensively studied, but with the 
development of more sophisticated methods of amino acid requirement estimation in 
horses, such as stable isotope infusion, it is now possible to more closely examine those 
requirements.  
NRC Method of Determination 
The NRC recommended minimum crude protein intakes are based on data from 
twelve studies that assessed nitrogen balance in mature sedentary horses fed a variety of 
diets (Table 2.1.) Nitrogen balance data was fitted to a broken line model, giving an 
estimate of 1.26 g CP/kg BW/d. Using the 95% confidence interval from that model gives 
a lower 95% confidence limit of 1.08 g CP/kg BW/d, an average requirement of 1.26 g 
CP/kg BW/d, and an upper 95% confidence limit of 1.44 g CP/kg BW/d, which 
correspond to the NRC’s minimum, average and elevated maintenance CP requirements 
respectively.  
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Table 2.1 Summary of data used to form NRC crude protein recommendations 
Author n= Age/Sex Avg. 
Weight 
N Intakes Major 
Protein 
Source 
DM Intake Estimated 
Requirement 
(Slade et al., 
1970) 
 
7 Adult 
Mares 
Horses, 
480 ± 
40.5 kg 
Fish: 72.5, 104.9, 
135.4, 165.9 g /d  
Corn gluten: 74.1, 
108.6, 141.6, 176.7 
g /d 
Fish meal 
Corn gluten 
meal 
~1.3% BW1 580 mg 
DP/kg BW/ d 
(Hintz and 
Schryver, 
1972) 
 
4 Mature/ 
Geldings 
Ponies, 
~160 kg2  
123, 186, 165 
mg/kg BW/d 
Soybean 
meal 
Linseed 
meal 
1.3 % BW 631 mg 
DP/kg BW/d 
3  (Reitnour 
and Salsbury, 
1972) 
 
4 Not 
specified 
Ponies, 
not 
specified 
24.8 (basal), 55.9 
(fishmeal), 56.6 
(soybean meal), 
57.5 (linseed meal) 
g/d3 
Fishmeal 
Soybean 
meal 
Linseed 
meal 
1.1 x 
maintenance 
requirement 
Not 
Specified3 
(Harper and 
Vanderno.Gw, 
1974) 
 
4 Mature/ 
Geldings 
Not 
specified 
81, 86, 94, 119, 
234, 333 mg N/kg 
BW/d 
Not 
Specified 
Not 
specified 
440 mg 
DP/kg BW/d 
(Reitnour and 
Salsbury, 
1976)  
 
4 Mature/ 
Not 
specified 
Ponies, 
180 kg 
22.1 (basal), 38.3 
(corn gluten), 39.5 
(corn gluten + Lys) 
and 42.5 (casein) 
g/d 
Corn gluten 
Corn gluten 
+Lys 
Casein 
Not 
specified 
Not 
specified4 
(Meyer, 1983)  1455 Various5 Various5 Various5 Various5 Various5 3.4g DCP/kg 
BW0.75 
(Meyer et al., 
1985) 
3 Not 
specified 
Ponies, 
~200 kg 
51.9 (control), 7.1 
(depletion) and 
47.9 (repletion) 6 
Casein Not 
specified 
500 mg 
DP/kg BW/d 
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Table 2.1 Continued     
(Freeman et 
al., 1986) 
4 Mature/ 
Geldings 
Not 
Specified 
81.8 g/d Not 
Specified 
Not 
Specified 
Not 
Specified7 
(Freeman et 
al., 1988) 
5 Mature/ 
Geldings 
~480 kg8 ~237mg N/kg 
BW/d 
Oat grain Not 
specified 
Not 
specified9 
(Gibbs et al., 
1988) 
3 Mature/ 
Geldings 
~135 kg 47.2 (coastal 
Bermuda), 59.6 
(low protein 
alfalfa), 71.4 (high 
protein alfalfa) 
Coastal 
Bermuda 
grass 
Low protein 
alfalfa 
High protein 
alfalfa 
2% BW   Not 
specified10 
(Martin et al., 
1996) 
3 Adult/ 
Geldings 
~400 kg 28.2 (low 
nitrogen), 95.1(low 
nitrogen + urea), 
and 98.2 (low 
nitrogen + soybean 
meal) g/d 
Urea 
Soybean 
Meal 
Not 
specified 
Not 
specified11 
(Olsman et al., 
2003) 
312 Various12 Ponies, 
Various12 
Various12 Various12 Various12 545 mg 
DP/kg BW/d 
1Calculated by dividing fixed intake by average BW. 
2Average weight of horses between the two trials conducted. 
3This study examined protein digestibility and nitrogen retention when protein was infused directly into the 
cecum. Therefore, intakes reflect the sum of dietary and cecally infused protein, and protein requirement 
was not specified. 
4This study examined responses in nitrogen balance to different sources of protein and given supplemental 
Lys. Therefore, protein requirement was not specified. 
5This data is a meta-analysis of 145 digestion trials, and equations to estimate the requirement account for 
differences in DM intake (n=136), N intake (n=145) and crude fiber intake (n=124). 
6The objective of this study was to measure endogenous and renal N losses in order to estimate the 
maintenance protein requirement for ponies.  
7 The objective of this study was to examine changes in nitrogen data in response to long term low intensity 
exercise. The data included in this chart represents period 1, an estimate of nitrogen balance at 
maintenance. 
8Average BW for the 9 horses studied. 
9This study examined differences in N retention in response to different levels of work. N intake differed 
by no more than 0.5% throughout the study. 
10The objective of this study was to determine prececal, postileal and total tract digestion. 
11The objective of this study was to examine urea utilization in the large intestine. 
12This study measured nitrogen balance in three ponies, and also conducted a meta-analysis of existing 
data. Specifications in this chart reflect both the meta-analysis and the experimentation. 
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The requirement for lysine is estimated as 4.3% of the crude protein requirement, 
with estimates being derived from linear regression of data that reported the lysine 
composition of the diet and nitrogen retention. Since the publication of the NRC in 2007, 
protein and amino acid requirements have been further studied and characterized. There 
has been an increase in research that focuses on determining which amino acids are 
limiting protein synthesis (Ohta et al., 2007; Winsco et al., 2011; Mastellar et al., 2016b), 
and what the requirements for those amino acids are in horses in different physiological 
states. At the time of publication of the 2007 NRC, there were no studies that had 
evaluated the lysine requirements of mature horses at maintenance. Therefore, 
recommendations for lysine intake were made not from studies specifically designed to 
estimate the lysine requirement, but by post hoc analysis of data that reported lysine 
intake and nitrogen retention. Since then, the focus of equine protein requirement 
research has shifted from studying protein requirements in general, to studying the 
requirements of individual amino acids, and there has been some innovation in the 
experimental methods used to assess whole-body protein metabolism in horses. 
 
Methods in Evaluating Amino Acid Adequacy 
Whole Body Protein Metabolism 
 Two ways to get a whole-animal estimate of use of dietary amino acids are 
nitrogen balance and stable isotope infusion. In order to understand how each of these 
methods works, it is important to understand the major fates of dietary and body amino 
acids. Figure 2.2 illustrates the major fates of amino acids in the body. These approaches 
each account for nitrogen utilization and excretion in different manners. While nitrogen 
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balance has been the classically accepted method of determining protein requirements, it 
is no longer considered the “gold standard” method in other species (WHO, 2007). Stable 
isotope infusion is a relatively new technique, and has recently been implemented in 
horses to study amino acid metabolism, estimate requirements of amino acids, and 
evaluate dietary amino acid adequacy.  
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Figure 2.2 Major fates of endogenous and dietary amino acids 
 
Amino acids consumed in the diet are either digested and absorbed, or excreted in the feces. Ammonia and 
amino acids from microbial activity and microbial bodies can also be absorbed from the hindgut, and the 
absorbed ammonia can be used to synthesize amino acids. Absorbed amino acids enter the blood amino 
acid pool where they are either used to synthesize protein, or are catabolized. Body protein can be broken 
down to its respective amino acids, and those amino acids can re-enter the blood amino acid pool, where 
they can be recycled into new body proteins, or catabolized. Conversely, body protein can remain intact 
and be sloughed off and lost (endogenous losses). Amino acids that are catabolized are broken into a 
carbon moiety, which can be completely oxidized to CO2, and expired in the breath (or recycled for use in 
synthesis of other body compounds), and a nitrogen moiety, which is converted to urea and excreted in the 
urine. 
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Nitrogen balance is calculated by determining the difference between nitrogen 
intake and nitrogen excretion in urine and feces. Positive nitrogen balance suggests net 
retention of nitrogen, presumably for use in synthetic processes, such as anabolism of 
skeletal muscle. Negative nitrogen balance suggests breakdown and excretion of body 
nitrogen stores. Therefore, nitrogen balance can be used as a broad assessment of the net 
use of dietary and body nitrogen. Classically, nitrogen balance has been used to 
determine the requirement for protein in animals of various stages of exercise (Freeman 
et al., 1988) and development (Hintz et al., 1971b), and on different diets (Graham-Thiers 
and Bowen, 2011). The NRC (NRC, 2007) provides estimates of crude protein 
requirements for horses at maintenance, exercising, during pregnancy, during lactation 
and during growth. These estimates account for maintenance protein requirements, as 
well as the amount of protein required to produce their respective products. However, 
when examining excretion of nitrogen, it is important to consider where the nitrogen in 
each excretory product could be coming from. Nitrogen in urine results from absorption 
of proteins, amino acids or ammonia, and eventual catabolism of either body amino acids, 
or excess dietary amino acids. Catabolism of amino acids results in free ammonia, which 
is converted to urea, and is targeted for excretion in the urine. Fecal nitrogen values 
reflect proteins and amino acids that were not absorbed by the animal, as well as 
endogenous proteins and amino acids that were excreted into the digestive tract.  
Together these values reflect an estimate of catabolized body nitrogen, endogenous 
nitrogen losses and unabsorbed dietary nitrogen (Figure 2). It is not possible to 
distinguish between the excretion of catabolized dietary amino acids and catabolized 
body amino acids in the urine. Additionally, values given do not distinguish between 
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excretion of endogenous and unabsorbed nitrogen in the feces. Thus, nitrogen balance is 
not a very specific measure of protein utilization, but more of an overall assessment of 
the balance between nitrogen intake and nitrogen excretion. Furthermore, while nitrogen 
balance can be used to compare nitrogen retention at different levels of crude protein, 
data suggests that it is not a sensitive enough measure to determine specific amino acid 
requirements in horses (Antilley et al., 2007; Malesky et al., 2013). In 2007, one study 
proposed that nitrogen retention may not be a suitable response criterion for assessing 
amino acid adequacy as compared to inadequacy (Antilley et al., 2007). For the purposes 
of that study, six yearling Quarter Horse fillies were used in a 3 x 3 Latin square design 
to evaluate nitrogen retention as a response criterion for amino acid studies. Treatments 
included an amino acid adequate control diet, a diet that was amino acid deficient and 
supplemented with urea, and an amino acid deficient diet fed in conjunction with oral 
dosing of essential amino acids.  There were significant differences in the biological 
value of nitrogen (nitrogen retention as a percent of nitrogen absorbed) between amino 
acid sufficient and insufficient diets. However, there was not a significant difference in 
nitrogen retention between the amino acid sufficient treatments and the amino acid 
insufficient treatment. Therefore, nitrogen retention did not appear to be a sensitive 
enough criterion to distinguish between amino acid sufficient diets and amino acid 
insufficient diets. Thus, estimates of amino acid requirements are now often made using 
newer techniques.  
A more contemporary assessment of amino acid utilization involves stable isotope 
infusion and measurement of isotope tracer kinetics. Much like nitrogen balance, stable 
isotope kinetics can address the effects of changing levels of limiting amino acids in the 
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diet, and can be used to estimate amounts of amino acids used for protein synthesis across 
different levels of intake. This technique is based on the principle that dietary amino 
acids that cannot be used for protein synthesis cannot be stored in the body and must be 
oxidized and excreted. Therefore, if an essential amino acid is limiting in the diet, protein 
synthesis will be limited by the amount of this amino acid and therefore all other amino 
acids will be in excess of what is needed for protein synthesis and they must be 
metabolized and excreted. For the purposes of this technique, an isotope of a non-limiting 
essential amino acid, often phenylalanine, is administered to use as an indicator (the 
indicator amino acid), and then differing levels of the limiting amino acid (the test amino 
acid) are fed, and breath and blood samples are collected. Plasma isotope enrichment 
represents dilution of the isotope in the plasma, and allows for the calculation of flux. 
Flux is an estimate of the rate of amino acid entry and exit from the free amino acid pool. 
Amino acids enter the pool through dietary intake, de novo synthesis and protein 
breakdown, and exit the free amino acid pool through protein synthesis, oxidation and 
conversion to other metabolites. The concentration of isotopic carbon dioxide in the 
breath represents the amount of indicator amino acid that was catabolized, and because 
the rates of oxidation can be determined, the non-oxidative losses of the amino acid, 
which includes use for protein synthesis and conversion to other metabolites, can be 
calculated. By comparing the rates of indicator amino acid oxidation between diets, what 
is essentially being compared is the rate of protein synthesis that can be supported by the 
diet. Thus, isotope tracer kinetics provide more direct insight into to differences in 
protein utilization between diets. Stable isotope infusion methods are well established in 
several species such as humans (Elango et al., 2008) and pigs (Moehn et al., 2005), but 
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more recently, methods have been validated for use in horses (Urschel et al., 2012). 
While these methods are useful for getting more specific estimates of whole-body protein 
metabolism, they do not give a general indication of whether animals are in a positive or 
negative nitrogen balance. Therefore, isotope tracer kinetics may be able to elucidate an 
adequate or optimal intake of a specific amino acid in a specific diet, but they cannot be 
used alone to determine whether horses are in a positive nitrogen balance, or are losing 
body nitrogen stores. 
 Nitrogen balance and isotope tracer kinetics, alone or taken together, are often 
used to assess the use of dietary protein on the whole-animal level. In addition to these 
methods, there are several other supporting measurements of certain metabolites that 
address the use of both dietary and tissue amino acids. These metabolites are often 
studied in conjunction with measures of whole-animal nitrogen metabolism to get a 
comprehensive representation of the way that both dietary and tissue amino acids are 
being metabolized.    
 
Plasma Metabolites  
Several plasma metabolites are used to assess dietary protein utilization and 
overall animal protein status. In order to get a complete picture of amino acid status and 
metabolism in an animal, there are several metabolites that can be considered. The results 
of these metabolite analyses should be taken together to address changes in protein 
metabolism in response to meal feeding, the animal’s use of dietary amino acids, 
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catabolism of skeletal muscle, and relative overall gains in skeletal muscle in response to 
feeding and exercise. 
Plasma amino acid concentration, in conjunction with other measures of dietary 
amino acid use, have been used as a method to determine limiting amino acid and amino 
acid requirements in species other than the horse (Mitchell et al., 1968; Ishibashi, 1985), 
but potential in horses at different levels of work and stages of development have yet to 
be fully explored (Graham-Thiers and Bowen, 2011). However, plasma amino acids are 
commonly compared across diets and used as an assessment of availability of amino 
acids following a meal.  Additionally, plasma amino acids are often compared over time 
after feeding a meal to characterize changes in amino acid metabolism with meal feeding. 
Finally, plasma amino acids can be used to estimate the requirements of amino acids. 
Plasma lysine data has been used to estimate the lysine requirement in mature 
thoroughbreds (Ohta et al., 2007), where samples were taken three hours after feeding a 
meal, and plasma lysine levels remained relatively constant with increasing levels of 
dietary lysine intake until the requirement was met, and then a breakpoint occurred and 
lysine concentrations increased with increasing lysine intake. Some plasma amino acid 
data suggests that the requirement for lysine may be higher than current 
recommendations (Ohta et al., 2007; Malesky et al., 2013). 
Plasma urea nitrogen (PUN) is often used as an indicator of dietary amino acid 
catabolism because there are two primary fates of dietary amino acids after absorption: 
protein synthesis or catabolism. Amino acid catabolism occurs either when protein 
synthesis is maximized and excess amino acids remain, or if the dietary supply of amino 
acids cannot support further protein synthesis due to one or more limiting amino acids. In 
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the case of catabolism, the carbon backbone of the amino acid is oxidized to CO2 and the 
amino moiety is converted to ammonia and subsequently urea is produced for excretion. 
Therefore, post-feeding PUN is an indicator of amount of dietary amino acid catabolism. 
PUN is commonly used to study amino acid sufficiency, and has been shown to respond 
quadratically to increasing intakes of limiting amino acid (Winsco et al., 2011; Coma et 
al., 1995). PUN levels decrease with increasing intake of a limiting amino acid until the 
requirement of the limiting amino acid is achieved, at which point PUN concentration 
reaches a plateau (Figure 2.3). The decreasing concentration of PUN results from the fact 
that as the level of supplementation of limiting amino acid is increased, a larger 
proportion of the other dietary amino acids are used to make protein, and a smaller 
proportion undergoes metabolism to urea. To study the efficiency of amino acid 
utilization, plasma samples are commonly taken while animals are in a postprandial state, 
as measurements taken in this state offer an estimate of the amount of urea that is 
entering the bloodstream as a result of metabolism of dietary amino acids. Post-feeding 
comparisons of PUN can be used to address differences in relative levels of catabolism of 
dietary amino acids between treatments. PUN is therefore often used as an indicator of 
relative dietary protein quality and utilization (Graham-Thiers and Kronfeld, 2005). 
However, it is important to note that since ammonia is absorbed from the hindgut 
(Bochroder et al., 1994), circulating PUN values reflect not only catabolism of dietary 
amino acids, but also absorption of nitrogen from the hindgut that could be occurring. 
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Figure 2.3 Patterns of PUN concentration change in response to amino acid 
availability 
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3-methyl histidine (3MH) is often used as a measure of skeletal muscle amino 
acid catabolism. 3MH is formed when the histidine in actin and myosin filaments is 
methylated during peptide bond formation (Young and Munro, 1978), and is part of the 
primary structure of actin and myosin (Johnson et al., 1967). Therefore, circulating 3MH 
is a by-product of the breakdown of actin and myosin fibers, and it is used as a marker of 
muscle catabolism (Gallagher et al., 1999). Comparing differences in 3MH across 
treatments can give an estimate of changes in muscle protein catabolism, which is of 
particular interest in aged animals, where rates of muscle protein catabolism exceeding 
rates of muscle protein anabolism leads to sarcopenia. 
Additionally, plasma creatinine levels are often compared across treatments to 
address differences in muscle masses between animals. Creatinine is formed from the 
physiochemical dehydration of creatine in muscle, which occurs at a rate of 
approximately 1.1-2.4% per day (Heymsfield et al., 1983a; Heymsfield et al., 1983b). 
Creatinine is used as a marker of muscle mass because creatine is only found in muscle, it 
is found at constant concentrations in muscle, and it is excreted at a uniform rate per mass 
of muscle (Heymsfield et al., 1983a). Therefore, animals can be adapted to a diet, and 
plasma or urinary creatinine can be used to estimate differences in muscle mass due to 
treatment. 
These indicators of amino acid utilization in combination with the above 
mentioned whole body estimates of protein and amino acid utilization provide a 
comprehensive assessment of the way that dietary amino acids are being metabolized and 
incorporated into and/or liberated from skeletal muscle. Comparing these measures in 
horses fed different levels of protein or amino acids may give a more comprehensive 
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view of the way that amino acids are being used to support anabolism and maintain 
skeletal muscle.    
Effect of Age on Protein Requirement 
There are a number of factors that could impact protein and amino acid 
requirements in aged horses, including poor dentition and decreased digestibility. In the 
late 1980’s, one study showed a decrease in digestibility of crude protein, along with 
phosphorus and calcium, in aged horses compared to mature horses (Ralston et al., 1989). 
A subsequent study conducted in 1996, however, did not show the same decreased 
digestibility of crude protein, despite similar diets to the previously conducted study 
(Christensen et al., 1996). Several causes of the difference in results have been proposed, 
including differences in body condition score and dentition of the experimental subjects, 
as well as the deworming program that the horses received throughout their life. It is 
therefore suggested that because horses in earlier studies were in low body condition, had 
poorer dentition, and had not been on a regular deworming program throughout their 
lives, that the decreased apparent digestibility and improvement with protein, calcium 
and phosphorus supplementation may be most beneficial to aged horses that are already 
in low body condition, have poor dentition, or have a history of parasite problems 
(Ralston et al., 2001). Additionally, sarcopenia—the loss of muscle mass and function—
is a condition that is observed most commonly in aged individuals (Santilli et al., 2014). 
Sarcopenia is thought to result from an imbalance in muscle protein synthesis and 
degradation rates (Combaret et al., 2009; Koopman and van Loon, 2009; Marcell, 2003), 
such that protein is being degraded at a faster rate than it is being made. Skeletal muscle 
protein synthesis is limited by the availability of amino acids and signaling pathways that 
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regulate protein synthesis are regulated in part by the presence of amino acids. Therefore, 
protein synthesis may be affected by advanced age, and increasing dietary protein intake 
or specific amino acid intake may stimulate muscle protein synthesis to ameliorate the 
age-related effects of sarcopenia. 
Data on the protein requirement of aged versus young animals is often conflicting, 
and there is a sparsity of data in equids. Some nitrogen balance studies in humans 
(Campbell et al., 2008) and isotope studies in horses (Wagner et al., 2013) do not support 
the idea that the protein requirement of old animals is significantly different from that of 
young animals. Conversely, some studies in humans using isotope tracer kinetics suggest 
that the optimal protein intake may be higher in aged subjects than what is currently 
recommended (Rafii et al., 2015). Many researchers argue that this disagreement can 
only be resolved with more data from newer methods such as stable isotope infusion, 
because older methods of assessment of dietary protein and amino acid adequacy such as 
nitrogen balance are no longer the “gold standard.” 
Although there is still debate as to whether the protein requirement of aged 
animals is elevated, there is evidence that imbalances in muscle protein synthesis, due to 
alterations in the responsiveness of the mechanistic target of rapamycin (mTOR) 
signaling pathway, could play a role in the development of sarcopenia. The 
supplementation of certain amino acids is of particular interest in this area of research 
because muscle protein synthesis can be limited by the availability of essential amino 
acids, and the mTOR signaling pathway can be regulated partially by amino acid 
presence. It has therefore been suggested that ensuring adequate supply of amino acids 
could positively alter protein synthesis signaling in aged animals, and ultimately decrease 
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the occurrence and severity of sarcopenia. Therefore, much recent research has focused 
on supplementation of specific amino acids that are either known or suspected to be 
limiting or to influence protein synthesis (Graham-Thiers and Kronfeld, 2005; Kim et al., 
2014; Luiking et al., 2014; Ellis et al., 2016; Kalhan et al., 2016), rather than a general 
increase in protein intake. Supplementation with these specific amino acids has the 
potential to supply the substrates and stimulus needed to improve muscle protein 
synthesis. 
Taken together, current data show promising evidence that targeted nutritional 
intervention such as specific amino acid supplementation has the potential to improve the 
negative effects of sarcopenia in aged animals. If these nutritional approaches are applied 
in the feed industry, they have the potential to positively impact quality of life for aged 
domestic animals.  
 
Amino Acid Supplementation and Protein Synthesis and Degradation Signaling 
The signaling molecule mTOR is a serine-threonine kinase that was first discovered 
in yeast, and is the crux of a highly conserved signaling pathway of eukaryotes that 
ultimately aids in regulation of cell growth. The functionality of mTOR is achieved by 
two different categories of protein complexes, mTORC1 and mTORC2, which have 
different structural and functional properties. mTORC1 is rapamycin sensitive, and is 
involved in ribosome biogenesis, transcription, translation, nutrient transport, and 
autophagy. This protein is the main focus of studies that examine effects of nutritional 
factors on protein synthesis. mTORC1 is composed of three protein sub-units; raptor, 
mLST8, and mTOR. mTORC2 is rapamycin insensitive and contributes to the regulation 
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of the actin cytoskeleton, which ultimately determines spatial control of cell growth. 
mTORC2 is composed of five protein sub-units including mSIN1, PRR5, rictor, mLST8, 
and mTOR (Hall, 2008). 
 
Function of Signaling Pathways 
The mTOR pathway functions mainly to regulate of cell growth. This regulation is 
achieved in a number of ways. First, mTOR influences translation of mRNA by 
stimulating ribosomal recruitment. mTOR activates eukaryotic translation initiation 
factor 4E (eIF4E,) by phosphorylation of its repressor, eIF4E binding protein 1(4EBP1.) 
Additionally, mTOR phosphorylates S6 kinase proteins (S6K,) which activates ribosomal 
protein S6 (rpS6), which promotes translation of mRNA that encodes for many 
components of ribosomal translation machinery (Hay and Sonenberg, 2004). Ultimately, 
mTOR stimulates cell growth by increasing transcription, which leads to an increase in 
protein synthesis.  
 
Tissue distribution and Cellular Localization 
mTOR is ubiquitous across tissues, and has been extensively studied in many tissues 
including myoblasts, fibroblasts (Drenan et al., 2004), adipocytes (Pham et al., 2000) and 
many other cell types. mTOR is predominantly localized to the endoplasmic reticulum 
and the golgi apparatus. However, mTOR has been shown to relocate to the cytoplasm or 
nuclear membrane in response to different inputs such as feedback of downstream 
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effectors. This translocation may play a role in regulating availability of TOR complexes 
for ribosome biogenesis (Drenan et al., 2004). 
 
Regulation 
mTOR is a signaling cascade for cell growth that is stimulated by several 
metabolic substrates and growth factors.  
Insulin and insulin-like growth factor (IGF) both effectively stimulate mTOR 
function through the same cascade. They bind at the membrane growth factor receptor, 
and induce intracellular recruitment and phosphorylation of insulin receptor substrate 
(IRS.) IRS then recruits phosphoinositidine-3-kinase (PI3K) to the plasma membrane, 
where PI3K produces the second messenger phosphatidylinositol-3,4,5-triphosphate 
(PIP3.) PIP3 recruits phosphoinositidine-dependent kinase-1 (PDK1) and Akt. PDK1 
activates Akt, which, when activated, phosphorylates tuberous sclerosis 2 (TSC2) and 
proline rich Akt substrate 40 (PRAS40,) which, when dephosphorylated, inhibit 
mTORC1 (Hall, 2008). Additionally, decreased Akt phosphorylation stimulates Forkhead 
Box Protein O1 (FOXO), which stimulates Atrogin-1, ultimately increasing protein 
degradation.   
 Inadequate cellular energy status ultimately inhibits mTOR function. High 
AMP/ATP ratios activate adenosine monophosphate-activated protein kinase (AMPK,) 
which is responsible for restoring cellular energy levels by inhibiting costly synthetic 
pathways. In the case of mTOR, AMPK phosphorylates TSC2, which then inhibits Rheb, 
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which has the net effect of inhibiting mTORC1. Additionally, AMPK directly 
phosphorylates and inactivates the raptor subunit of mTORC1(Hall, 2008). 
Nutrients appear to be the most influential inputs for the TOR pathway, as amino 
acids can stimulate mTORC1 in the absence of other pathway stimulants, such as insulin, 
but the absence of amino acids prevents function of mTORC1. Therefore, amino acids 
play a sort of rate limiting role in the flow of the mTOR pathway. Although amino acid 
availability appears to be a crucial point of regulation, the mechanism it employs has not 
yet been well described (Hall, 2008). It is suggested that the pathway involves vascular 
protein-sorting-associated protein 34 (VPS34) interaction with Ras related GTP binding 
protein (Rag) which translocates to influence mTOR function (Laplante and Sabatini, 
2009). 
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Figure 2.4 Schematic representation of proteins of interest in the mTOR pathway 
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Equine Research on Protein Synthesis and Degradation Signaling 
Although there has been extensive research on the mTOR pathway in food animals, 
the amount of research in horses is significantly smaller, and in much earlier stages than 
in other animals. With respect to stimulants of the mTOR pathway in horses, one study 
examined the effects of refeeding after an 18-hour feed withholding on the 
phosphorylation of proteins in the mTOR pathway. This study found a significant 
increase in phosphorylation of rpS6 and 4EBP1 after refeeding. Therefore, it was 
concluded that feeding resulted in stimulation of the mTOR pathway independent of Akt 
phosphorylation, and that dietary amino acids seemed to be the main stimulator of these 
effects (Urschel et al., 2011). Additionally, an insulin clamp study that included biopsies 
of the gluteus showed that insulin administration increased phosphorylation of Akt, 
4EBP1, and rpS6 at all observed rates of infusion (1.2 mU/kg/min, 3 mU/kg/min, and 6 
mU/kg/min.) This data suggests anabolic effects of insulin on muscle in horses via 
mTOR signaling (Urschel et al., 2014).  
There has also been some research on the effect of developmental stage on mTOR 
pathway proteins. One study examined the effect of stage of development on mTOR 
protein responsiveness. The study used six yearlings, six two-year-old horses and six 
mature horses, and examined the effect of refeeding on phosphorylation of Akt, S6K1, 
rpS6 and 4EBP1. The study found a significant increase in phosphorylation of all proteins 
after refeeding, but also found that yearlings had the most responsive phosphorylation of 
proteins, suggesting that the increased muscle protein synthesis observed during growth 
could be resultant from increased rates of muscle protein synthesis following 
consumption of a meal (Wagner and Urschel, 2012). Additionally, in a study that 
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compared protein metabolism between mature (7-14 years) and aged horses (22-26 
years,) no difference was found between the age groups in phosphorylation of Akt, rpS6, 
or 4EBP1. There was significantly lower phosphorylation of S6K in aged horses, but it 
could not be concluded that the observed decrease in phosphorylation of S6K resulted in 
a decrease in muscle protein synthesis, because there were not significant differences in 
whole-body protein kinetics between the two age groups (Wagner et al., 2013). 
Finally, there is data that suggests an effect of exercise on expression of a number of 
proteins, including some of those that comprise the mTOR pathway. Data showed an 
increase in expression of four unspecified genes related to the mTOR signaling pathway 
during recovery from exercise in thoroughbreds. The effect of exercise on gene 
expression was found to be most prominent four hours after exercise as compared to 
immediately after exercise. This data suggests mTOR as one of a number of pathways 
that contribute to improved skeletal muscle integrity and hypertrophy in response to 
exercise in horses (McGivney et al., 2009). 
Some data in humans suggests that muscle protein synthesis in response to 
anabolic stimulus may be delayed in older subjects (Drummond et al., 2008). However, 
the mechanism of this delay has yet to be elucidated, as regulation of protein synthesis is 
governed by many undefined factors both at the post-transcriptional level (Zacharewicz 
et al., 2014), as well as upstream of transcription. However, as previously mentioned 
supplementation with additional protein has not consistently been shown to improve 
measures of protein synthesis (Campbell et al., 2008; Rafii et al., 2015). 
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Conclusion 
Current recommendations for protein and lysine intakes are the result of data 
derived from nitrogen balance studies, and linear regression of data to estimate the lysine 
and crude protein requirements. However, as the focus of equine research has shifted 
from examination of protein requirements, to examining specific amino acid 
requirements, there are many questions left to be answered. New techniques have given 
us the ability to study the effect of feeding different levels of proposed limiting amino 
acids on whole-body protein metabolism, muscle mass, and regulation of muscle protein 
metabolism. With more sensitive methods, we can now explore the possible benefits of 
supplementing individual amino acids in aged animals, which are known to experience 
sarcopenia. 
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Chapter 3. Rationale and Objectives 
Rationale 
Relatively little is known about the amino acid requirements of horses, and there 
is currently no data examining the amino acid requirements of aged horses specifically.  
Since aged horses (>20 years old) now comprise approximately 7% of the equine 
population in the United States (APHIS, 2005), there is an appreciable population of aged 
horses whose requirements have not been extensively explored. However, aged horses, 
like other aged animals, may exhibit muscle wasting as an effect of sarcopenia. The 
muscle mass and integrity loss associated with sarcopenia has the potential to be 
particularly detrimental to aged horses, who are often still athletically active, and may 
therefore be more at risk of injury.  
The observed muscle mass loss associated with sarcopenia results from an 
imbalance in the rates of muscle protein synthesis and muscle protein degradation, which 
ultimately cause a net loss of muscle mass (Combaret et al., 2009; Koopman and van 
Loon, 2009; Marcell, 2003). The rates of muscle protein synthesis and degradation are 
influenced by several factors, including nutritional factors such as insulin levels and the 
presence of amino acids.  
In a previous study examining the effects of amino acid supplementation in aged 
horses (Graham-Thiers and Kronfeld, 2005), animals were fed a grass forage at a rate of 
1.8% BW/d and a commercial concentrate at a rate of 0.5% BW/d for a total of 14 weeks. 
Treatments included a control diet without the supplementation of amino acids, and an 
experimental diet with additional lysine (20 g/d) and threonine (15 g/d). Subjects were 
grouped by age, including a young group (~10 years) and an old group (~ 20 years). 
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Results showed that supplementation of amino acids improved visual muscle scores and 
decreased circulating PUN and 3MH concentrations in horses of both age groups. While 
this study addressed some indicators of dietary protein utilization such as PUN and 3MH, 
it did not examine more robust measures of protein metabolism such as nitrogen balance, 
whole-body rates of protein synthesis and breakdown, or the signaling pathway 
associated with muscle protein synthesis. Therefore, it is unclear what improvements in 
protein metabolism caused improvements in the measured variables. Furthermore, the 
treatments used in the previous study were not isonitrogenous and therefore we cannot 
conclude that the improvements observed were not simply due to the intake of additional 
nitrogen.  
 
Objectives 
The aim of this study was to expand on the research done by Graham-Thiers and 
Kronfeld in 2005 by taking more robust measures of protein utilization and metabolism. 
Therefore, the current study used similar treatments, in addition to adding a diet that was 
supplemented with lysine, threonine and methionine, as methionine has been identified as 
the second or third limiting amino acid in other livestock species (Richardson and 
Hatfield, 1978; Boisen et al., 2000).  
The objective of this study was to determine the effects of lysine and threonine 
(LYS/THR) or lysine, threonine and methionine (LYS/THR/MET) supplementation in 
aged horses by measuring indicators of whole-body protein utilization including plasma 
urea and amino acid concentrations, nitrogen balance, creatinine concentrations, whole-
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body phenylalanine kinetics and the activation of proteins associated with synthesis and 
degradation signaling. 
 
Chapter 4. Materials and Methods 
Animals, Housing and Feeding  
Six aged horses were obtained from Maine Chance Farm at the University of 
Kentucky. At the beginning of the study, horses weighed an average of 560 ± 40 kg, and 
had an average body condition score of 5.75 (Henneke body condition scoring scale).  
Horses were aged (20 ± 1.1 years) and included three mares and three geldings. Breeds 
included four Thoroughbreds, one Quarter Horse, and one Standardbred. Before the start 
of adaptation, horses were kept in a pasture where they had ad libitum access to grass. 
Horses underwent an initial adaptation to stalls, paddocks and hay cubes for 
approximately 2 weeks before the initiation of the experimental treatments and sample 
collection protocols. During the day, horses were turned out into a paddock together 
wearing grazing muzzles to prevent grass consumption. Horses were individually fed and 
housed overnight and during collection procedures in 3.6 m x 3.6 m stalls. Weights were 
measured using an electronic scale (TI-500, Transcell Technology Inc., Buffalo Grove, 
IL) on days 0, 4, 9 and 14 of each experimental period, and feed quantity offered was 
adjusted accordingly, as described below.  The protocol was approved by a University of 
Kentucky Institutional Animal Care and Use Committee before the start of collection 
procedures. 
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Experimental Treatments and Diets 
The experimental treatments included a control (CON) treatment concentrate, a 
concentrate supplemented with lysine and threonine (LYS/THR) and a concentrate 
supplemented with lysine, threonine, and methionine (LYS/THR/MET). Horses received 
each of the experimental treatments in a replicated Latin square design. All three diets 
were designed to meet or slightly exceed nutrient requirements for mature horses at 
maintenance (NRC, 2007). Horses were fed half of the daily intake of both hay and 
concentrate at 7:30 am and the remainder was fed at 2:30 pm. Feed refusals from the 
previous day’s meals were collected directly before offering the next morning’s meal.  
For all three treatments, timothy hay cubes (Timothy Balance Cubes, Guelph, Canada; 
Table 4.1 & Table 4.2) were offered at a rate of 1.8% body weight per day. The three 
experimental concentrates (Table 4.1, 4.2, 4.3) were designed to be isocaloric and 
isonitrogenous, and were kept isonitrogenous by altering the ratios of soybean hulls and 
wheat middlings (Table 4.3). Concentrates were offered at 0.5% of body weight per day. 
Experimental concentrates included a control diet (CON), LYS/THR which was designed 
to be nutritionally similar to CON but supplemented with lysine and threonine, and 
LYS/THR/MET which was designed to be nutritionally similar to CON but 
supplemented with lysine, threonine and methionine. The targeted levels of 
supplementation were 40 mg/kg BW/d of lysine, 30 mg/kg BW/d of threonine and 10 
mg/kg BW/d of methionine above CON intakes (Table 4.2). Feed samples were collected 
on d 15 of each sampling period and sent to DairyOne (Ithaca, NY, USA) for proximate 
analysis. Amino acid compositions of the feeds were analyzed using HPLC (see 
“Analysis” section for further description of methods).  
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Table 4.1 As-fed nutrient composition of feeds1 
 Timothy 
hay cubes 
CON LYS/THR LYS/THR/
MET 
Dry matter (%) 92.00 ± 0.4 90.50 ± 0.2 90.40 ± 0.7 90.30 ± 0.1 
Digestible energy (Mcal/kg) 1.78 ± 0.04 2.31 ± 0.01 2.24 ± 0.02 2.21 ± 0.0 
Crude protein (%) 11.1 ± 0.3 12.1 ± 0.2 12.2 ± 0.1 12.3 ± 0.2 
Acid detergent fiber (%) 38.5 ± 1.1 23.9 ± 0.4 27.8 ± 1.0 28.4 ± 0.2 
Neutral detergent fiber (%) 55.0 ± 0.8 40.7 ± 1.0 42.9 ± 0.6 43.1 ± 0.5 
Water soluble carbohydrates (%) 5.2 ± 0.5 4.1 ± 0.5 3.3 ± 0.3 3.3 ± 0.2 
Ether soluble carbohydrates (%) 3.9 ± 0.9 2.9 ± 0.1 2.7 ± 0.6 2.6 ± 0.8 
Starch (%) 0.7 ± 0.2 13.8 ± 0.9 11.3 ± 0.6 10.9 ± 0.6 
Crude Fat (%) 1.1 ± 0.3 3.2 ± 0.1 3.7 ± 0.8 3.0 ± 0.1 
Ash (%) 9.2 ± 0.1 6.8 ± 0.1 7.0 ± 0.2 6.8 ± 0.3 
Calcium (%) 0.74 ± 0.01 1.03 ± 0.04 0.98 ± 0.05 1.00 ± 0.05 
Phosphorus (%) 0.21 ± 0.02 0.58 ± 0.01 0.52 ± 0.01 0.52 ± 0.03 
Magnesium (%) 0.31 ± 0.02 0.35 ± 0.01 0.32 ± 0.01 0.33 ± 0.01 
Potassium (%) 1.73 ± 0.13 0.96 ± 0.01 0.92 ± 0.01 0.93 ± 0.00 
Sodium (%) 0.07 ± 0.01 0.18 ± 0.02 0.16 ± 0.02 0.15 ± 0.02 
Chloride (%) 0.26 ± 0.02 0.41 ± 0.05 0.57 ± 0.03 0.58 ± 0.06 
Sulfur (%) 0.19 ± 0.01 0.17 ± 0.01 0.17 ± 0.01 0.21 ± 0.01 
Iron (mg/kg) 291 ± 13 413 ± 13 475 ± 5 490 ± 30 
Table 4.1 Continued     
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Zinc (mg/kg) 110 ± 21 165 ± 7 151 ± 5 170 ± 8 
Copper (mg/kg) 45 ± 8 47 ± 1 42 ± 2 48 ± 1 
Manganese (mg/kg) 108 ± 8 105 ± 5 81 ± 3 94 ± 2 
Molybdenum (mg/kg) 0.83 ± 0.12 1.47 ± 0.23 1.10 ± 0 1.10 ± 0.10 
Cobalt (mg/kg) 0.51 ± 0.17 1.93 ± 0.17 1.66 ± 0.04 1.92 ± 0.11 
1Values are mean ± standard deviation of 3 samples measured in duplicate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
Table 4.2 As-fed amino acid composition of feeds1 
 Timothy 
hay cubes 
CON LYS/THR LYS/THR/MET 
Alanine (%) 0.49 ± 0.08 0.44 ± 0.04 0.42 ± 0.03 0.40 ± 0.00 
Arginine (%) 0.50 ± 0.04 0.62 ± 0.07 0.57 ± 0.05 0.54 ± 0.01 
Aspartate + 
Asparagine (%) 
0.73 ± 0.15 0.67 ± 0.06 0.65 ± 0.06 0.64 ± 0.03 
Glutamate + 
Glutamine (%) 
1.04 ± 0.20  1.58 ± 0.20 1.43 ± 0.11 1.35 ± 0.04 
Glycine (%) 0.43 ± 0.06 0.53 ± 0.03 0.54 ± 0.02 0.51 ± 0.02 
Histidine (%) 0.21 ± 0.04 0.27 ± 0.03 0.25 ± 0.03 0.24 ± 0.02 
Isoleucine (%) 0.41 ± 0.05 0.38 ± 0.04 0.34 ± 0.06 0.31 ± 0.05 
Leucine (%) 0.69 ± 0.09 0.66 ± 0.05 0.63 ± 0.05 0.59 ± 0.01 
Lysine (%) 0.43 ± 0.03 0.46 ± 0.03 1.14 ± 0.06 1.10 ± 0.05 
Methionine (%) 0.22 ± 0.02 0.21 ± 0.01 0.24 ± 0.02 0.41 ± 0.03 
Phenylalanine (%) 0.47 ± 0.06 0.44 ± 0.06 0.40 ± 0.06 0.38 ± 0.03 
Proline (%) 0.62 ± 0.19 0.56 ± 0.05 0.53 ± 0.05 0.50 ± 0.04 
Serine (%) 0.40 ± 0.02 0.42 ± 0.09 0.46 ± 0.06 0.45 ± 0.06 
Threonine (%) 0.38 ± 0.03 0.32 ± 0.05 0.83 ± 0.09 0.88 ± 0.11 
Tyrosine (%) 0.29 ± 0.02 0.33 ± 0.01 0.33 ± 0.02 0.32 ± 0.01 
Valine (%) 0.52 ± 0.08 0.49 ± 0.05 0.43 ± 0.08 0.40 ± 0.05 
1Values are mean ± standard deviation of 3 samples. 
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Table 4.3 As-fed composition of experimental concentrates1, % 
Ingredient CON LYS/THR LYS/THR/MET 
Wheat middlings 34.7 19.0 16.3 
Soybean hulls 32.3 45.6 48.1 
Ground oats 25.0 25.0 25.0 
Dehydrated alfalfa (17%) 3.75 3.75 3.75 
Limestone 1.70 1.35 1.25 
Soybean oil 1.00 1.30 1.30 
Biofos2 0.60 1.20 1.30 
Salt 0.50 0.50 0.50 
Horse Vitamin Premix3 0.25 0.25 0.25 
Magnesium oxide 0.15 0.20 0.20 
Horse Trace Mineral 
Premix4 
0.10 0.10 0.10 
Selenium 0.03 0.03 0.03 
L - Lysine - HCl (98%) 0.000 1.035 1.035 
L - Threonine (98%) 0.000 0.675 0.680 
DL - Methionine DL (99%) 0.000 0.013 0.245 
1Values are expressed as a percentage of the concentrate 
2Monocalcium phosphate 
3Contains vitamin A, vitamin E, vitamin D, vitamin K, choline, biotin, folic acid, riboflavin, pantothenic 
acid, niacin, vitamin B12, pyroxidine and thiamin 
4Contains zinc, manganese, copper, iodine, and cobalt 
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Table 4.4 Nutrient intakes for each of the experimental treatment groups1 
 CON LYS/THR LYS/THR/MET 
Dry Matter  (g/kg BW*d) 21.1 21.1 21.1 
Acid Detergent Fiber (g/kg BW*d) 8.1 8.3 8.4 
Neutral Detergent Fiber (g/kg BW * d) 11.9 12.0 12.1 
Digestible Energy (Mcal/kg BW*d) 0.044 0.043 0.043 
Crude Protein  (g/kg BW*d) 2.6 2.6 2.6 
Calcium (mg/kg BW*d) 184.7 182.2 183.2 
Phosphorus (mg/kg BW*d) 66.8 63.8 63.8 
Lysine (mg/kg BW*d) 100 134 132 
Threonine (mg/kg BW*d) 84 110 112 
Methionine (mg/kg BW*d) 51 52 62 
Alanine (mg/kg BW*d) 110 109 108 
Arginine (mg/kg BW*d) 120 118 116 
Aspartate + Asparagine (mg/kg BW*d) 164 163 163 
Glutamate + Glutamine (mg/kg BW*d) 266 258 255 
Glycine (mg/kg BW*d) 104 105 103 
Histidine (mg/kg BW*d) 51 50 50 
Isoleucine (mg/kg BW*d) 92 90 89 
Leucine (mg/kg BW*d) 158 156 154 
Phenylalanine (mg/kg BW*d) 106 104 103 
Proline (mg/kg BW*d) 139 137 136 
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Table 4.4 Continued    
Serine (mg/kg BW*d) 93 96 95 
Tyrosine (mg/kg BW*d) 68 68 68 
Valine (mg/kg BW*d) 119 116 114 
 
1Daily intakes were calculated based on daily intakes of 1.8% BW/d of forage and 0.5%BW/d of the 
respective concentrate. 
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Experimental Design 
Horses were assigned to receive each of the experimental treatments in a 
replicated Latin square design, and were studied for a total of 15 days for each treatment. 
Each period included 9 days of adaptation (d 0-9) to the diet. Adaptation was followed by 
three days of total urine and feces collection for determination of nitrogen balance and 
urinary creatinine output (d 10-12). Pre- and post- feeding blood collection was 
conducted on d 12 for determination of plasma glucose, insulin, plasma urea nitrogen 
(PUN), creatinine, and amino acid concentrations. Muscle biopsy samples of the gluteus 
medius were taken before (d 13) and after (d 14) consuming a meal on d 14 for 
determination of the relative abundances of proteins associated with the mTOR pathway 
(Akt, rpS6 (ribosomal protein S6), AMPK (AMP-activated protein kinase) and Atrogin-
1). A primed, constant isotope infusion of [1-13C]phenylalalnine was conducted on d 15 
for estimation of whole body protein synthesis and degradation. 
 
Sample Collection 
Urine and Feces Collection 
At 6:30 am on d 10, horses were fitted with total urine and feces collection 
harnesses (Equisan Nappy, South Melbourne, Australia) and urine and feces were 
collected every 4 h for 72 h. Collection harnesses were modified to ensure complete 
collection of urine in females by creating funnels to ensure that urine output was 
channeled into the urine collection bag. Weight and volume of urine output, and weight 
of feces output was recorded at each 4 h collection. Urine was pooled over 24 h periods 
in air-tight containers stored at room temperature. After each 24 h period of collection, 
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urine was homogenized by shaking and a 100 mL sub-sample of the 24 h pooled urine 
was collected. Urine sub-samples were stored in sterile, air-tight containers at -20o C until 
further analysis. Feces were pooled over 24 h periods in 20-gallon plastic bags stored at 
room temperature. After each 24 h period of collection, feces were homogenized by hand, 
and a 1 kg sub-sample of the 24 h pooled feces was collected. Fecal samples were stored 
in bags with round wire closure (Fisherbrand Bags with Round-Wire Closure, Fisher 
Scientific, Waltham, MA) at -20o C until further analysis.  
 
Pre- and Post- Feeding Blood Samples 
On d 12 at 6:00, am horses were aseptically fitted with a jugular vein catheter 
(Hospira, Lake Forest, IL) and venous blood samples were taken 30 minutes (Figure 4.1) 
before the morning meal (t=-30), directly before the morning meal (t=0) and 30, 60, 90, 
120, 150, 180, 210 and 240 minutes after consuming the morning meal. Blood samples 
were collected into heparinized evacuated containers (BD, Franklin Lakes, NJ), and 
centrifuged at 1,500 x g for 10 minutes at 4o C. Plasma was collected and stored in 
microcentrifuge tubes at -20o C until further analysis.  
 
Muscle Biopsies 
Muscle biopsies were collected on the mornings of d 13 and d 14 (Figure 4.1). On 
d 13 at 6:30am, after the final urine and feces collection, diapers were removed. 
Approximately ten minutes before the biopsy procedure was to be conducted, horses 
were sedated with a weight appropriate dose of xylazine HCl (1.1mg/kg BW; AnaSed, 
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Lloyd, Inc., Shenandoah, IA). Horses were placed in veterinary stocks and the biopsy 
area was desensitized subcutaneously with 3 mL of lidocaine, and intramuscularly to a 
depth of 1.5 inches with 10 mL of lidocaine (Lidoject, Butler Schein Animal Health, 
Dublin, OH). The lidocaine was allowed to take effect for approximately 2 min and then 
a muscle sample was taken from the gluteus medius using a Bergstrom needle as 
previously described (Urschel et al., 2011). After the biopsy procedure was complete, the 
incision site was closed with a single stitch. Horses were given 2 g of phenylbutazone, 
allowed to recover from sedation, and were then fed their morning meals. On the morning 
of d 14 horses were fed their morning meal at 7:30 am. Horses consumed their morning 
concentrate within 30 minutes, and were offered their hay cubes after finishing their 
concentrate. Approximately 90 minutes after beginning the morning meal, biopsy 
procedures began. Biopsy procedures for d 14 were identical to those of d 13, except that 
samples were taken from the opposite side of the horse. Muscle samples were 
homogenized in 7 µL of homogenization buffer (20mM HEPES, 2mM EGTA, 50mM 
sodium fluoride, 100mM potassium chloride, 0.2mM EDTA, and 50mM β-
glycerophosphate [pH, 7.4], 20µL protease inhibitor per mL(Protease Inhibitor Cocktail, 
Sigma Aldrich, St. Louis, MO)), per mg of wet tissue as previously described (Wagner 
and Urschel, 2012) and stored in microcentrifuge tubes at -80o C until further analysis.  
 
Stable Isotope Infusion Procedures 
During stable isotope infusion procedures, isotopic sodium bicarbonate was 
infused at a constant rate, and isotopic CO2 was measured in breath samples to estimate 
total CO2 production (Urschel et al., 2009). Then, isotopic phenylalanine was 
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administered orally, and isotopic CO2 production from phenylalanine, in conjunction 
with total CO2 production data was used to calculate the amount of phenylalanine 
oxidation occurring, which then enabled the estimation of phenylalanine use for protein 
synthesis. 
At 6:00am on d 15, a catheter was placed in the jugular vein and stable isotope 
infusion procedures were conducted (Figure 4.1) as previously described (Tanner et al., 
2014). Horses were kept in a steady metabolic state for the entirety of the isotope infusion 
procedures by feeding small portions of the daily meal every 30 minutes (Urschel et al., 
2012). At approximately 7:00 am horses were fed 3/48 of their daily meal (t=-90 BC), 
and 30 minutes later horses were fed 1/48 of their daily meal (t=-60 BC) to begin 
maintenance of the metabolic steady state. Thirty minutes (t=-30 BC) before beginning 
[13C]sodium bicarbonate infusion a baseline blood and breath sample were taken, and 
horses were then fed 1/48th their daily meal. Breath samples were collected into gas 
impermeable bags, and blood samples were collected into evacuated heparinized 
containers. Fifteen minutes before (t=-15 BC) [13C]sodium bicarbonate infusion, 
additional baseline breath and blood samples were taken. [13C]sodium bicarbonate 
isotope was infused directly into the jugular vein catheter. Bicarbonate was administered 
as a 5.3 mol/kg prime dose given immediately before beginning constant infusion, and 
then infused at a rate of 4.4 mol/kg/h using cordless infusion pumps. Breath samples 
were collected 30 and 15 minutes before the beginning of [13C]sodium bicarbonate 
infusion, and at 30, 60, 75, 90, 105 and 120 minutes of [13C]sodium bicarbonate infusion. 
1/48th of the meal was given every 30 minutes during [13C]sodium bicarbonate infusion. 
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After two hours of [13C]sodium bicarbonate infusion, infusion pumps were removed and 
[1-13C]phenylalanine administration began. 
Prime and constant doses of [1-13C]phenylalanine administration were previously 
validated (Mastellar et al., 2016a). [1-13C]phenylalanine isotope was given as a 10.3 
mol/kg prime dose and at a rate of 3.6 mol/kg each half hour for constant infusion. The 
prime dose of [1-13C]phenylalanine was included with the first constant dose at the 
beginning of [1-13C]phenylalanine infusion. [1-13C]phenylalanine constant infusion was 
achieved by top-dressing half the hourly dose of [1-13C]phenylalanine on 1/48th of the 
daily meal. Meals were administered every 30 minutes directly following collection of a 
breath and a blood sample. Horses generally readily consumed meals, and any feed 
refusals were weighed and re-fed with the following meal. [1-13C]phenylalanine was 
administered and samples were collected for four hours.  
Breath samples were analyzed on the day they were collected for the ratio of 
13CO2:12CO2 using a non-dispersive infrared isotope analyzer (IRIS-3, Wagner Analysen 
Technik Vetriebs GmbH, Bremen, Germany).  Blood samples were centrifuged at 1,500 x 
g for 10 minutes at 4o C, and then plasma was collected and stored at -20 °C until further 
analysis.  
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Figure 4.1 Sampling timeline for collection of pre/post fed blood samples, muscle 
biopsies, and stable isotope infusion samples. 
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Laboratory Analysis and Calculations 
Feed Amino Acids 
Feed samples were ground to particles smaller than 1mm, and subjected to acid 
hydrolysis in 6M HCl (AOAC method 994). Briefly, 300 µL of 100mM norleucine was 
added to 0.2 g of feed sample as an internal standard. 12 mL of 6M HCl was added to the 
tube, the tubes were purged with N2 gas, and were heated for 24 hours at 110o C.  For the 
determination of feed methionine levels, feed samples first underwent performic acid 
oxidation procedures prior to acid hydrolysis procedures (AOAC method 994). 
Phenylisothiocyanate derivatives of the samples were prepared as previously described 
(Urschel et al., 2011) and were analyzed by reverse phase HPLC (3.9 × 300 mm PICO- 
TAG reverse phase column, Waters, Milford, MA). Briefly, samples were filtered 
through µm syringe filters and 25 µL aliquots were dried and frozen. Samples were then 
re-dreid with trimethylamine, 1M NaAc, and methanol. Samples were derivatized with 
trimethylamine, phenyl isothiocyanate and methanol. Samples were then re-diluted with 
100 µL of buffer and loaded onto the HPLC. Concentrations of amino acids in the 
samples were estimated using crystalline amino acid standards that underwent the same 
derivitization process as feed samples. Feed sample amino acid analysis was run in 
duplicate on a sample from each period.  
 
Urine and Feces Samples 
The nitrogen content of the feeds, urine and feces samples were determined using 
an automated carbon/nitrogen analyzer (Elementar C/N analyzer, Hanau, Germany).  For 
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analysis, 500 mg feces, 500 mg feed and 1 g urine were run in duplicate. Urine was 
acidified using 10% phosphoric acid such that the final pH of the sample was 
approximately 2. Nitrogen parameters were calculated as described in Table 4.5. 
Creatinine concentration was determined by enzymatic assay using a commercially 
available kit (Sigma Aldrich, St. Louis, MO) and analyzed by spectrophotometry in a 96 
well plate at 570 nm.  
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Table 4.5 Calculation of nitrogen balance parameters 
Parameter Calculation 
Nitrogen absorbed Nitrogen intake – nitrogen excretion in feces 
Nitrogen retained Nitrogen intake – (Nitrogen excreted in urine + 
nitrogen excreted in feces) 
Nitrogen absorbed as a 
percentage of intake 
(Nitrogen Absorbed/Nitrogen Intake)*100 
Nitrogen retained as a 
percentage of intake 
(Nitrogen Retained/Nitrogen Intake)*100 
Nitrogen retained as a 
percentage of absorbed 
(Nitrogen Retained/Nitrogen Absorbed)*100 
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Pre- and Post- Feeding Blood Samples 
Pre- and post- feeding blood samples were analyzed for plasma glucose, insulin, urea 
nitrogen, amino acids, and creatinine concentrations. Plasma glucose concentrations were 
determined by automated enzymatic assay using a YSI 2700 Select Analyzer (YSI Inc., 
Life Sciences, Yellow Springs, OH). Plasma insulin concentrations were determined 
using a Coat-A-Count radioimmunoassay kit (Siemens, Munich, Germany) that has 
previously been validated for use in horses (Tinworth et al., 2011).  Plasma urea nitrogen 
concentrations were determined using a spectrophotometric assay, as described 
previously (Urschel et al., 2007).  Plasma amino acid concentrations were determined via 
the HPLC analysis of the phenylisothiocyanate derivatives, as previously described 
(Urschel et al., 2011). Briefly, samples were deproteinized using 10K spin filters, and 50 
µL aliquots were dried and frozen. Samples were then re-dreid with trimethylamine, 1M 
NaAc, and methanol. Samples were derivatized with trimethylamine, phenyl 
isothiocyanate and methanol. Samples were then re-diluted with 100 µL of buffer and 
loaded onto the HPLC.  
 
Muscle Samples 
Muscle samples were analyzed for the abundance and activation 
(phosphorylation) of proteins associated with the regulation of muscle protein synthesis 
(Akt, rpS6, AMPK) and degradation (Atrogin-1), by Western Blotting based on 
previously described methods (Wagner and Urschel, 2012; Mastro et al., 2014). Protein 
content of the sample homogenate was determined by Bradford assay and samples were 
diluted in Laemmli buffer to achieve a protein concentration of 2 μg/μL.  Samples were 
52 
 
loaded into polyacrylamide gels and separated by electrophoresis. All gels were run in 
duplicate. Protein bands were transferred to polyvinylidene diflouride membranes and 
stained using fastgreen stain (0.1%w/v Fast Green FCF, 50% methanol, 40% ddH2O, and 
10% glacial acetic acid). Stained bands were quantified by densitometry using Quantity 
One computer software (Bio-Rad Laboratories, Hercules, CA). Membranes were then de-
stained and blocked by incubating for ten minutes in 0.5% fat-free milk solution in the 
Snap i.d protein detection system (Millipore, Darmstadt, Germany). After 10 minutes, 
blocking solution was pulled through the membrane under suction and discarded. 
Membranes were incubated on Snap i.d. in primary antibody for the phosphorylated 
(active) protein and 0.5% fat free milk solution as indicated in Table 4.6, and then pulled 
through the membrane.  
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Table 4.6 Primary antibody procedures for Western Blotting 
Protein Dilution Incubation Time 
P-Akt (Ser473)  1:600 1 h rocking in Snap i.d. at room 
temperature 
Total Akt 1:600 1 h rocking in Snap i.d. at room 
temperature 
P-rpS6 
(Ser235/236 and 
Ser240/244)  
1:1,200 1 h rocking in Snap i.d. at room 
temperature 
Total rpS6  1:6,000 30 minutes rocking in Snap i.d. at 
room temperature 
P-AMPK(Thr172) 1:600 1 h rocking in Snap i.d. at room 
temperature 
Total AMPK 1:600 30 minutes rocking in Snap i.d. at 
room temperature 
Atrogin-1 1:600 30 minutes rocking in Snap i.d. at 
room temperature 
α-Tubulin 1:600 30 minutes rocking in Snap i.d. at 
room temperature 
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Membranes were then washed using Snap i.d., incubated with a goat anti-rabbit 
secondary antibody conjugated to horseradish peroxidase (Cell Signaling, Danvers, 
MA) for 20 minutes at room temperature, and washed again in Snap i.d. Membranes were 
developed with a chemiluminescent kit (ECL Prime Western Blotting Detection Kit, GE 
Healthcare) and developed by use of a film processor. Membranes were then stripped and 
re-probed with a second antibody to determine the total amount of the protein of interest. 
Only total abundance of Atrogin-1 was measured, and it was therefore standardized to α-
tubulin, which has been previously used as a total protein standardization in equine 
skeletal muscle samples (Tiley et al., 2008). Protein band densities were measured by 
densitometry using Quantity One software (Bio-Rad Laboratories, Hercules, CA). Final 
values are expressed in arbitrary units as a ratio of phosphorylated to total protein, and 
are corrected for differences in background by averaging the background density and for 
loading volume using band densities of fastgreen stain bands. The abundances of 
phosphorylated forms of Akt, rpS6, and AMPK were expressed as a ratio to density of 
the total protein bands and the abundance of Atrogin-1 is expressed as a ratio to α-tubulin 
to correct for total protein. The value for the pre-fed CON group was set at 1.0 arbitrary 
units, and values therefore reflect changes in abundances relative to the pre-fed CON 
group horses.   
 
Stable Isotope Infusion 
Breath samples from [13C]bicarbonate and  [13C]phenylalanine infusion were 
analyzed on the day they were collected. Breath samples were analyzed for the ratio of 
13CO2 to 12CO2  using an isotope ratio infrared spectrometer (IRIS-3; Wagner Analysen 
Technik Vetriebs GmbH, Bremen, Germany).  
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Plasma samples were analyzed by Metabolic Solutions Inc. (Nashua, NH) for 
[13C]phenylalanine enrichment, as previously described (Wagner et al., 2013). The 
average enrichment of isotope at a steady state was calculated in breath samples taken 
during [13C]bicarbonate infusion and blood and breath samples taken during 
[13C]phenylalanine infusion (Table 4.6). CO2 production was calculated using breath 
samples taken during bicarbonate infusion at the plateau of 13CO2:12CO2 (Table 4.7). 
Phenylalanine entering the free amino acid pool through intake was calculated based on 
the phenylalanine content of the feed ingredients and was corrected assuming 40% 
phenylalanine digestibility for hay cubes (Gibbs et al., 1988) and 70% phenylalanine 
digestibility for concentrates (Farley et al., 1995) 
 Additionally, extraction by the small intestinal and liver cells prior to entry into 
general circulation was assumed to be 26.5% (Tanner, 2014).Whole-body phenylalanine 
flux (Hsu et al., 2006) and phenylalanine oxidation(Urschel et al., 2012) were calculated 
as previously described (Table 4.7).  Values from the above described parameters were 
used to estimate phenylalanine release from protein breakdown and non-oxidative 
phenylalanine disposal (Table 4.7). Although phenylalanine can be converted to tyrosine, 
that conversion is not accounted for in these equations because it should be equal 
between treatments since both phenylalanine and tyrosine intakes were equal between 
treatments. Therefore, differences in non-oxidative phenylalanine disposal between 
treatments represent differences in whole-body protein synthesis between treatments.   
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Table 4.7 Calculation of phenylalanine kinetics parameters1 
Parameter Equation 
Phenylalanine Intake =(0.4*Phenylalanine in cubes)+(0.7*Phenylalanine in 
concentrate)-(0.265*(0.4*Phenylalanine in 
cubes)+(0.7*Phenylalanine in concentrate)) 
Isotope Enrichment2 =[Rs-Rb/(1+ Rs)- Rb]x100 
CO2 Production3 = i × [(Ei/Eb) – 1] × [0.0224 mL/μmol CO2] 
Phenylalanine Flux(Q)4 = i × [(Ei/Ep) – 1]  
= I+N+B 
= Z+E+M 
Rate of Phenylalanine 
Entry into the Free 
Amino Acid Pool4 
= I + B 
Phenylalanine 
Oxidation(E)5 
= F13CO2 (1/Ep – 1/Ei) × 100 
Phenylalanine Release 
from Protein Breakdown6 
= Q – I 
Rate of Phenylalanine 
Exit from Free Amino 
Acid Pool 
= E + Z 
Non-Oxidative 
Phenylalanine Disposal 
= Q – E 
= estimate of whole-body protein synthesis  
1 Phenylalanine flux and phenylalanine oxidation were calculated as previously described (Urschel et al., 
2012). 
2 Rs= (m+1):(m) in enriched sample; Rb=  (m+1):(m) in sample at natural abundance; m= molecular ion. 
(Wilson et al., 2000) 
3i=rate of isotope infusion (mg/kg BW/h); Ei= enrichment of isotope solution; Eb= plateau breath 
enrichment. (Urschel et al., 2009) 
4Q= flux; i= rate of isotope infusion; Ei= enrichment of isotope solution; Ep= plateau plasma enrichment 
(Hsu et al., 2006). I= intake; N= de novo synthesis; B= Phenylalanine release from protein breakdown; Z= 
protein synthesis; E= oxidation; M= conversion to other metabolites. Q = Rate of Phe entry into the free 
amino acid pool = Rate of Phe exit from the free amino acid pool. 
5 F13CO2= rate of 13CO2released by oxidation of isotopic Phe oxidation (µmol/kg BW/h) (Hsu et al., 2006) 
6Horses do not synthesize phenylalanine de novo, therefore, N=0. 
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Statistical Analysis 
Data were analyzed using the mixed procedure of SAS (Version 9.4) with a model 
appropriate for a replicated Latin square design. Plasma glucose, insulin, urea, amino acid 
concentrations, nitrogen balance, urinary creatinine, Western blot data, body weight and 
body condition were analyzed using repeated measures analysis with treatment, period, 
time, treatment by time interaction and period by time interaction as the fixed effects, 
horse nested in period as the subject and time as the repeated variable. The 
variance/covariance matrix used was first order auto regressive.  Phenylalanine kinetics 
and plasma creatinine data were analyzed using a one-way ANOVA, with treatment and 
period as the fixed effects and horse as a random effect. When model p-values were 
significant, means were separated using the Tukey-adjusted pdiff option. Statistical 
significance was considered at P < 0.05 and trends were considered at 0.05 < P < 0.10.   
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Chapter 5. Results 
Body Weight and Body Condition Score 
 There was no significant effect of period (P=0.26) or treatment (P=0.21) on body 
condition score. There was a significant effect of treatment on body weight, where the 
estimated gain in body weight was higher for the LYS/THR/MET treatment than for the 
LYS/THR treatment (-11.0 kg BW; P=0.043; Figure 5.1A). It is interesting to note that 
horses appear to have lost weight while on the LYS/THR treatment, but gained weight 
while on the CON and LYS/THR/MET treatments. There was also a significant effect of 
period on change in body weight, where horses had losses in body weight in periods 2 
and 5, but gained weight in all of the other periods, leading to lower weight gains in 
periods 2 and 5 (P<0.1; Figure 5.1B). 
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Figure 5.1 Changes in weight (kg) over the 15 d experimental period in aged horses 
receiving concentrates with no amino acid supplementation (CON), lysine and 
threonine supplementation (LYS/THR) or lysine, threonine and methionine 
supplementation (LYS/THR/MET)1 
A: By treatment 
  
 
B: By period 
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Plasma Glucose and Insulin Concentrations 
In comparison to the CON treatment, LYS/THR was supplemented with 34 
mg/kg/d of lysine and 26 mg/kg/d of threonine and LYS/THR/MET provided an 
additional 32 mg/kg/d of lysine, 28 mg/kg/d of threonine and 10 mg/kg/d of methionine 
(Table 4.4). Feeding increased plasma glucose and insulin concentrations over time 
(P<0.05), with concentrations peaking at approximately 60 and 120 minutes respectively 
(Figure 5.1). There was no effect of treatment (Glucose, P=0.57; Insulin, P=0.22), period 
(Glucose, P=0.20; Insulin, P=0.16) or the treatment by time interaction (Glucose, P=0.21; 
Insulin, P=0.39) on plasma glucose or insulin concentrations. There was a significant 
interaction of period and time (P=0.024) for glucose concentration, but not for insulin 
concentration (P=0.21). 
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Figure 5.2 Pre-feeding (t=-30,0min) and post-feeding (t=30-240min) plasma glucose 
and insulin concentrations in aged horses receiving concentrates with no amino acid 
supplementation (CON), lysine and threonine supplementation (LYS/THR) or 
lysine, threonine and methionine supplementation (LYS/THR/MET)1 
A: Plasma glucose concentrations  
 
B: Plasma Insulin Concentrations  
 
Values are least squares means ± standard error. 
1CON and LYS/THR/MET, n=5; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
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Plasma Urea Nitrogen Concentrations 
PUN concentrations in response to feeding were measured as an indicator of 
differences in catabolism of dietary amino acids between treatments. Samples were taken 
before and after a meal on d 10 of collection. PUN concentrations were not affected by 
time or treatment by time interaction (P>0.05; Figure 5.3 A). PUN concentrations were 
affected by treatment, with concentrations being higher for LYS/THR and 
LYS/THR/MET treatments compared to CON (P=0.0058; Figure 5.3 B). Additionally, 
PUN concentrations were significantly affected by period (P<0.001; Figure 5.3 C), but 
not by the interaction of period and time (P=0.51). 
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Figure 5.3 Pre-feeding (t=-30,0min) and post-feeding (t=30-240min) PUN 
concentrations in aged horses receiving concentrates with no amino acid 
supplementation (CON), lysine and threonine supplementation (LYS/THR) or 
lysine, threonine and methionine supplementation (LYS/THR/MET) 
A: PUN concentrations over time after feeding1  
 
B: PUN concentrations by treatment1  
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Figure 5.3 Continued 
C: PUN concentrations by period2 
 
Values are least squares means ± standard error. 
1 CON and LYS/THR/MET, n=5; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection. 
2 Period 1, 2, 3, 5 and 6, n = 3; Period 4, n=2. For period 4, one horse’s data was omitted due to a systemic 
infection.   
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Plasma Creatinine Concentrations 
Plasma creatinine concentrations were measured as an indicator of differences in 
muscle mass between treatments. Samples taken directly before the morning meal on d 
10 were analyzed. Creatinine concentrations were not affected by treatment (P= 0.29; 
Figure 5.4 A), but tended to be affected by collection period, (P= 0.066; Figure 5.4 B), 
where period 5 was higher than the other periods. 
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Figure 5.4 Plasma creatinine concentrations in aged horses receiving concentrates 
with no amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation 
(LYS/THR/MET)1 
A: By treatment2  
 
B: By period3   
 
Values are least squares means ± standard error. 
1Creatinine concentration in plasma taken directly before morning meal on d 10. 
2 CON and LYS/THR/MET, n = 6; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
3Period 1, 2, 3, 5 and 6 n = 3; Period 4, n=2. For period 4, one horse’s data was omitted due to a systemic 
infection.  
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Plasma Amino Acid Concentrations 
After consuming the morning meal, the concentrations of most plasma amino 
acids increased (Table 5.1). Plasma lysine and threonine concentrations were higher 
approximately 60 minutes after consuming a meal (P<0.0001) for the horses receiving 
LYS/THR and LYS/THR/MET compared to CON. Additionally, plasma methionine 
concentrations were (P=0.012) higher in horses following consumption of LYS/THR as 
well as LYS/THR/MET (P<0.0001) compared to CON (Table 5.1). There was a 
significant treatment by time interaction for lysine, threonine, and methionine, where 
plasma concentrations peaked earlier and more sharply when the amino acids were 
supplemented. The concentrations of all measured amino acids except glutamate, glycine 
and tryptophan were affected by time (P<0.005; Table 5.1). The concentrations of four 
amino acids other than the supplemented amino acids were affected by treatment or 
treatment by time interaction, including glutamate, leucine, phenylalanine and serine. 
Additionally, alanine concentration tended to be affected by treatment and glycine 
concentration tended to be affected by treatment by time interaction. Glutamate 
concentration was higher for CON than for LYS/THR (22.7 mmol/L; P=0.038) and 
tended to be higher for CON than for LYS/THR/MET (16.7 mmol/L; P=0.094). Leucine 
concentration tended to be higher for CON than for LYS/THR/MET (11.3 mmol/L; 
P=0.064).  Phenylalanine concentration tended to be higher for CON than for LYS/THR 
(3.4 mmol/L; P=0.069) and was higher for CON than for LYS/THR/MET (5.5 mmol/L; 
P=0.001). Serine concentration was higher for LYS/THR than for LYS/THR/MET (39.8 
mmol/L; P=0.025). Alanine concentration tended to be higher for LYS/THR and for 
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LYS/THR/MET (35.7 mmol/L;P=0.060). Glycine concentration tended to be affected by 
the treatment by time interaction (P=0.052; Table 5.1). 
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Table 5.1 Pre-feeding (t=-30,0) and post-feeding (t=30-240) plasma amino acid 
concentrations (µmol/L) in aged horses receiving concentrates with no amino acid 
supplementation (CON), lysine and threonine supplementation (LYS/THR) or lysine, 
threonine and methionine supplementation (LYS/THR/MET) 
 
Amino Acid Time 
(min) 
CON LYS/THR LYS/THR/
MET 
   
Lysine -30 142±22 151±22 155±22 Treat Time Treat*Time 
 0 153±22 154±25 146±22 <0.0001 <0.0001 0.0091 
 30 161±22 239±25 191±23    
 60 205±22 370±26 324±22 Period Period*Time  
 90 213±22 372±25 330±22 0.3819 0.5263  
 120 200±22 355±25 354±22    
 150 193±22 345±25 334±22    
 180 185±22 314±25 292±22    
 210 194±22 321±25 299±22    
 240 192±22 317±25 308±22    
Threonine -30 192±31 286±33 294±31 Treat Time Treat*Time 
 0 185±31 264±33 279±31 <0.0001 <0.0001 0.0112 
 30 189±32 352±33 304±32    
 60 226±31 439±34 408±31 Period Period*Time  
 90 229±31 451±33 442±31 0.2985 0.6206  
 120 218±31 463±33 462±31    
 150 219±31 462±33 452±31    
 180 205±31 426±33 430±31    
 210 205±31 453±33 436±31    
 240 211±31 452±33 447±31    
Methionine -30 50±6 53±6 61±6 Treat Time Treat*Time 
 0 49±6 56±6 57±6 <0.0001 <0.0001 0.0056 
 30 50±6 67±6 68±6    
 60 58±6 77±7 95±6 Period Period*Time  
 90 59±6 79±6 94±6 0.4266 0.7153  
 120 58±6 78±6 107±6    
 150 56±6 81±6 105±6    
 180 53±6 74±6 94±6    
 210 55±6 78±6 95±6    
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Table 5.1 Continued     
 240 53±6 76±6 101±6    
Alanine -30 284±26 294±28 269±26 Treat Time Treat*Time 
 0 277±26 288±28 261±26 0.0707 <0.0001 0.7352 
 30 325±26 313±28 254±27    
 60 351±26 348±29 332±26 Period Period*Time  
 90 364±26 374±28 352±26 0.5159 0.0230  
 120 360±26 398±28 358±26    
 150 350±26 397±28 354±26    
 180 342±26 379±28 334±26    
 210 339±26 400±28 348±26    
 240 345±26 395±28 368±26    
Arginine -30 99±11 93±12 91±11 Treat Time Treat*Time 
 0 100±11 93±12 87±11 0.3513 <0.0001 0.9849 
 30 109±11 109±12 94±11    
 60 151±11 136±12 130±11 Period Period*Time  
 90 148±11 144±12 136±11 0.0549 0.0339  
 120 149±11 151±12 146±11    
 150 142±11 144±12 139±11    
 180 133±11 137±12 128±11    
 210 143±11 145±12 130±11    
 240 140±11 138±12 139±11    
Aspartate -30 34±6 23±7 26±6 Treat Time Treat*Time 
 0 33±6 19±7 24±6 0.1423 <0.0001 0.9754 
 30 39±6 28±7 29±6    
 60 52±6 35±7 39±6 Period Period*Time  
 90 52±6 38±7 40±6 0.1796 0.0710  
 120 53±6 39±7 44±6    
 150 50±6 39±7 43±6    
 180 49±6 33±7 38±6    
 210 49±6 39±7 39±6    
 240 48±6 36±7 40±6    
Asparagine -30 73±12 65±13 68±12 Treat Time Treat*Time 
 0 54±12 67±13 61±12 0.1752 <0.0001 0.8027 
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Table 5.1 Continued     
 30 84±12 76±13 85±13    
 60 93±12 91±14 99±12 Period Period*Time  
 90 96±12 101±13 97±12 0.0095 0.1282  
 120 98±12 99±13 105±12    
 150 90±12 107±13 95±12    
 180 85±12 94±13 95±12    
 210 84±12 104±13 103±12    
 240 86±12 99±13 106±12    
Glutamate -30 135±25 113±26 122±25 Treat Time Treat*Time 
 0 164±25 106±26 114±25 0.0306 0.6156 0.7584 
 30 137±25 119±26 118±26    
 60 144±25 115±27 132±25 Period Period*Time  
 90 144±25 122±26 126±25 0.7754 0.4578  
 120 135±25 123±26 129±25    
 150 143±25 128±26 133±25    
 180 134±25 104±26 114±25    
 210 128±25 120±26 118±25    
 240 126±25 114±26 120±25    
Glutamine -30 589±41 604±45 627±41 Treat Time Treat*Time 
 0 560±41 630±45 606±41 0.1724 <0.0001 0.6631 
 30 611±41 688±45 633±42    
 60 715±41 728±47 735±41 Period Period*Time  
 90 748±41 735±45 750±41 0.9084 0.2041  
 120 714±41 802±45 766±41    
 150 694±41 785±45 748±41    
 180 672±41 732±45 698±41    
 210 664±41 774±45 730±41    
 240 679±41 757±45 751±41    
Glycine -30 820±71 851±74 887±71 Treat Time Treat*Time 
 0 809±71 876±74 886±71 0.3547 0.1034 0.0523 
 30 832±71 908±74 878±72    
 60 865±71 871±75 923±71 Period Period*Time  
 90 876±71 841±74 921±71 0.7593 0.0734  
72 
 
Table 5.1 Continued    
 120 826±71 903±74 884±71    
 150 830±71 874±74 865±71    
 180 816±71 815±74 816±71    
 210 798±71 855±74 844±71    
 240 804±71 831±74 872±71    
Histidine -30 84±5 82±5 84±5 Treat Time Treat*Time 
 0 81±5 75±5 81±5 0.7902 <0.0001 0.875 
 30 81±5 83±5 83±5    
 60 96±5 92±6 93±5 Period Period*Time  
 90 99±5 91±5 98±5 0.1172 0.3868  
 120 96±5 102±5 101±5    
 150 98±5 97±5 98±5    
 180 91±5 89±5 93±5    
 210 90±5 95±5 95±5    
 240 93±5 95±5 98±5    
Isoleucine -30 92±6 89±7 95±6 Treat Time Treat*Time 
 0 93±6 89±7 91±6 0.6208 <0.0001 0.9588 
 30 97±6 95±7 88±7    
 60 115±6 106±7 106±6 Period Period*Time  
 90 114±6 107±7 108±6 0.1372 0.0087  
 120 111±6 107±7 110±6    
 150 105±6 106±7 103±6    
 180 98±6 98±7 93±6    
 210 100±6 100±7 96±6    
 240 100±6 98±7 104±6    
Leucine -30 176±9 165±10 175±9 Treat Time Treat*Time 
 0 178±9 165±10 167±9 0.0473 <0.0001 0.9760 
 30 183±9 175±10 163±10    
 60 213±9 189±11 195±9 Period Period*Time  
 90 214±9 193±10 195±9 0.0051 0.0008  
 120 203±9 194±10 198±9    
 150 194±9 190±10 183±9    
 180 180±9 175±10 163±9    
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Table 5.1 Continued    
 210 182±9 176±10 171±9    
Phenylalanine -30 75±3 72±3 73±3 Treat Time Treat*Time 
 0 77±3 72±3 69±3 0.0013 <0.0001 0.8790 
 30 77±3 77±3 70±3    
 60 87±3 80±4 80±3 Period Period*Time  
 90 87±3 78±3 79±3 0.2283 0.0007  
 120 85±3 82±3 81±3    
 150 81±3 80±3 76±3    
 180 78±3 76±3 70±3    
 210 79±3 78±3 74±3    
 240 78±3 76±3 77±3    
Proline -30 95±12 93±14 96±12 Treat Time Treat*Time 
 0 98±12 90±14 92±12 0.6404 <0.0001 0.7393 
 30 108±12 109±14 96±13    
 60 148±12 135±14 130±12 Period Period*Time  
 90 152±12 136±14 139±12 0.2038 0.0120  
 120 152±12 142±14 151±12    
 150 147±12 147±14 142±12    
 180 145±12 140±14 136±12    
 210 157±12 152±14 144±12    
 240 151±12 145±14 159±12    
Serine -30 380±33 386±34 375±33 Treat Time Treat*Time 
 0 390±33 392±34 367±33 0.028 <.0001 0.4080 
 30 388±33 432±34 352±34    
 60 460±33 458±35 423±33 Period Period*Time  
 90 468±33 456±34 447±33 0.4154 0.0054  
 120 449±33 490±34 446±33    
 150 444±33 476±34 432±33    
 180 433±33 452±34 396±33    
 210 444±33 471±34 411±33    
 240 450±33 467±34 433±33    
Tryptophan -30 11±2 8±2 7±2 Treat Time Treat*Time 
 0 8±2 7±2 6±2 0.2677 0.4424 0.6513 
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Table 5.1 Continued    
 30 7±2 6±2 9±2    
 60 9±2 7±3 7±2 Period Period*Time  
 90 10±2 8±2 12±2 0.6520 0.3525  
 120 10±2 9±2 9±2    
 150 12±2 6±2 7±2    
 180 7±2 6±2 6±2    
 210 8±2 7±2 6±2    
 240 7±2 11±2 7±2    
Tyrosine -30 119±9 121±9 132±9 Treat Time Treat*Time 
 0 120±9 123±9 132±9 0.1087 <0.0001 0.1357 
 30 130±9 136±9 129±9    
 60 152±9 147±10 152±9 Period Period*Time  
 90 154±9 144±9 150±9 0.0170 0.0049  
 120 141±9 153±9 158±9    
 150 142±9 160±9 153±9    
 180 133±9 146±9 144±9    
 210 146±9 149±9 151±9    
 240 141±9 148±9 156±9    
Valine -30 353±21 309±25 323±21 Treat Time Treat*Time 
 0 346±21 317±25 311±21 0.1753 0.0004 0.8161 
 30 358±21 333±25 303±22    
 60 403±21 346±26 345±21 Period Period*Time  
 90 408±21 346±25 351±21 0.3619 0.0833  
 120 395±21 363±25 355±21    
 150 387±21 358±25 345±21    
 180 370±21 333±25 316±21    
 210 373±21 347±25 332±21    
 240 375±21 336±25 347±21    
Values are least squares means ± standard error. 
1CON and LYS/THR/MET, n = 6; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
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Nitrogen Retention 
Nitrogen intakes and urinary and fecal nitrogen excretions were not significantly 
different between treatments (P>0.05; Table 5.2), and there was therefore no significant 
difference in nitrogen absorption, nitrogen retention, nitrogen absorbed as a percentage of 
intake, nitrogen retained as a percentage of intake, or nitrogen retained as a percentage of 
absorbed between treatments (P>0.05; Table 5.2).   
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Table 5.2 Nitrogen consumption, urinary excretion, fecal excretion and nitrogen retention 
in aged horses receiving concentrates with no amino acid supplementation (CON), lysine 
and threonine supplementation (LYS/THR) or lysine, threonine and methionine 
supplementation (LYS/THR/MET) over a three day collection period by treatment1 
 CON LYS/THR LYS/THR/
MET 
P-values 
(Treatment) 
Nitrogen Intake (g/kg 
BW) 
0.38±0.005 0.39±0.005 0.38±0.005 0.2660 
Nitrogen Excreted in 
Urine (g/kg BW) 
0.21±0.03 0.22±0.03 0.22±0.03 0.8399 
Nitrogen Excreted in 
Feces (g/kg BW) 
0.21±0.009 0.22±0.010 0.21±0.009 0.5328 
Nitrogen Absorbed2 
(g/kg BW) 
0.17±0.008 0.17±0.009 0.18±0.008 0.6946 
Nitrogen Retained3 
(g/kg BW) 
-0.04±0.02 -0.06±0.03 -0.05±0.03 0.8562 
Nitrogen Absorbed as a 
Percentage of Intake4(%) 
45.3±1.9 43.2±2.3 45.6±2.0 0.6763 
Nitrogen Retained as a 
Percentage of Intake5(%) 
-10.6±5.9 -15.2±6.8 -12.4±6.1 0.8441 
Nitrogen Retained as a 
Percentage of 
Absorbed6(%) 
-26.8±12.5 -38.9±14.6 -27.9±13.2 0.7499 
 
Values are least squares means ± standard error. 
1 (CON and LYS/THR/MET, n = 6; LYS/THR, n=5). For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
2Nitrogen absorbed was calculated by taking the difference between nitrogen intake and fecal nitrogen 
excretion. 
3Nitrogen retained was calculated by taking the difference between nitrogen intake and the sum of fecal and 
urinary nitrogen excretion. 
4Nitrogen absorbed as a percentage of intake = (Nitrogen Absorbed/Nitrogen Intake)*100. 
5Nitrogen retained as a percentage of intake = (Nitrogen Retained/Nitrogen Intake)*100. 
6Nitrogen retained as a percentage of absorbed = (Nitrogen Retained/Nitrogen Absorbed)*100. 
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 Nitrogen intake was significantly lower for periods 2, 4 and 6 than for 
periods 1 and 3 (Figure 5.5A; P<0.05), and nitrogen intake was significantly lower for 
period 5 than all other periods (Figure 5.5A; P<0.05). Nitrogen absorbed was 
significantly lower for periods 4, 5 and 6 than for periods 1, 2 and 3 (Figure 5.5A; 
P<0.05). Urinary nitrogen, fecal nitrogen, nitrogen retention, nitrogen absorbed as a 
percentage of intake, nitrogen retained as a percentage of intake, and nitrogen retained as 
a percentage of absorbed were not significantly different between periods (P>0.05; Table 
5.3).  
Nitrogen intake, absorption, and urinary and fecal excretions of nitrogen were not 
significantly different between days of collection (P>0.05). However, nitrogen absorption 
tended to be lower on d 10 than on d 11 (Figure 5.5B; -0.018 g N/kg BW/d; P=0.085). 
There was no significant difference in nitrogen retention, nitrogen absorbed as a 
percentage of intake, nitrogen retained as a percentage of intake, or nitrogen retained as a 
percentage of absorbed between days of collection (Table 5.3; P>0.05).   
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Table 5.3 Nitrogen consumption, urinary excretion, fecal excretion and nitrogen 
retention in aged horses receiving concentrates with no amino acid supplementation 
(CON), lysine and threonine supplementation (LYS/THR) or lysine, threonine and 
methionine supplementation (LYS/THR/MET) by day of collection 
 d 10 d 11 d 12 P-values 
(Time) 
Nitrogen Intake(g/kg 
BW) 
0.37±0.005 0.38±0.005 0.39±0.005 0.0958 
Nitrogen Excreted in 
Urine(g/kg BW) 
0.21±0.027 0.23±0.026 0.22±0.026 0.7015 
Nitrogen Excreted in 
Feces(g/kg BW) 
0.21±0.008 0.21±0.008 0.21±0.008 0.7129 
Nitrogen Absorbed3 
(g/kg BW) 
0.16±0.007 0.18±0.007 0.18±0.007 0.0827 
Nitrogen Retained2 
(g/kg BW) 
-0.05±0.026 -0.05±0.025 -0.04±0.025 0.8141 
Nitrogen Absorbed as a 
Percentage of Intake4(%) 
42.2±1.9 46.1±1.9 45.7±1.9 0.2047 
Nitrogen Retained as a 
Percentage of Intake5(%) 
-13.7±6.3 -13.9±6.1 -10.7±6.1 0.8960 
Nitrogen Retained as a 
Percentage of 
Absorbed6(%) 
-35.1±14.3 -31.2±13.8 -27.4±13.8 0.9142 
Values are least squares means ± standard error.  
1Periods 1, 2, 3, 5 and 6, n = 3; Period 4, n=2. For period 4, one horse’s data was omitted due to a systemic 
infection.  
2Nitrogen retained was calculated by taking the difference between nitrogen intake and the sum of fecal and 
urinary nitrogen excretion. 
3Nitrogen absorbed was calculated by taking the difference between nitrogen intake and fecal nitrogen 
excretion. 
4Nitrogen absorbed as a percentage of intake = (Nitrogen Absorbed/Nitrogen Intake)*100. 
5Nitrogen retained as a percentage of intake = (Nitrogen Retained/Nitrogen Intake)*100. 
6Nitrogen retained as a percentage of absorbed = (Nitrogen Retained/Nitrogen Absorbed)*100. 
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Figure 5.5 Nitrogen intake and absorption in aged horses receiving concentrates 
with no amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET)  
A: By period1  
 
  
 
B: By day of collection 
 
Values are least squares means ± standard error 
1 Period 1, 2, 3, 5 and 6, n=3, period 4, n=2. For period 4, one horse’s data was omitted due to a systemic 
infection.  
 
 
 
80 
 
Urinary Creatinine Output 
Urinary creatinine output did not differ significantly (Figure 5.6 A; P=0.58) 
between treatments. There was a significant effect of period on urinary creatinine output. 
Urinary creatinine output was significantly higher in period 1, 2, 4 and 5 than in period 3 
and 6 (Figure 5.6 B; P<0.05). Additionally, there was a significant effect of day of 
collection on urinary creatinine output. Urinary creatinine output tended to be higher on d 
10 of collection than on d 11 (Figure 5.5 C; 12.2 mmol/d; P=0.058) and was significantly 
higher on d 10 of collection than on d 12 (Figure 5.5 C; 21.8 mmol creatinine/d; P= 
0.0003). 
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Figure 5.6 Daily creatinine output in aged horses receiving concentrates with no 
amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) 
A: By treatment1  
 
B: By period2  
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Figure 5.6 Continued 
C: By day of collection3 
 
1CON and LYS/THR/MET, n = 6; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
2Period 1, 2, 3, 5 and 6, n = 3; Period 4, n=2. For the period 4, one horse’s data was omitted due to a 
systemic infection.  
3Creatinine output for each collection day within a period 
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Phenylalanine Kinetics 
There was no significant effect of treatment on CO2 production, phenylalanine 
flux, phenylalanine intake, phenylalanine oxidation, non-oxidative phenylalanine disposal 
or phenylalanine release from protein breakdown (P > 0.05; Table 5.4). However, it is 
noted that for all three treatments, phenylalanine release from protein breakdown is 
consistently higher than non-oxidative phenylalanine disposal. 
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Table 5.4 Whole-body phenylalanine kinetics in aged horses receiving 
concentrates with no amino acid supplementation (CON), lysine and threonine 
supplementation (LYS/THR) or lysine, threonine and methionine 
supplementation (LYS/THR/MET)1 
 CON LYS/THR LYS/THR
/MET 
p-value 
(Treatment) 
p-value 
(Period) 
CO2 
Production 
(µmol/kg 
BW/h) 
15993±366 15004±452 15415±366 0.2769 0.5769 
Phenylalanine 
Flux 
(µmol/kg/h) 
59±2.98 61±3.57 61±2.98 0.8447 0.2685 
Phenylalanine 
Intake 
(µmol/kg/h) 
9.9±0.11 9.7±0.13 9.7±0.11 0.2774 <0.0001 
Phenylalanine 
Released from 
Protein 
Breakdown 
(µmol/kg/h) 
49±2.99 51±3.59 52±2.99 0.8144 0.2785 
Phenylalanine 
Oxidation 
(µmol/kg/h) 
19±1.12 19±1.19 18±1.12 0.1898 0.6489 
Non-oxidative 
Phenylalanine 
Disposal 
(µmol/kg/h) 
40±2.32 42±2.66 44±2.32 0.6154 0.1604 
Values are least squares means ± standard error.  
1CON and LYS/THR/MET, n = 6; LYS/THR, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
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Muscle Protein Synthesis and Degradation Signaling   
 Akt and rpS6 
Akt and rpS6 proteins are associated with stimulation of protein synthesis signaling. rpS6 
activation (amount of phosphorylated corrected for total) was significantly higher 
(P<0.0001; Figure 5.8) after meal feeding, but there was no significant effect of meal 
feeding on Akt activation (P=0.11; Figure 5.7). Additionally, there was no significant 
effect (P>0.05; Figure 5.7 & 5.8) of treatment, treatment by time interaction, period or 
period by time interaction on the activation of Akt or rpS6.  
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Figure 5.7 Before the morning meal (Pre) and after the morning meal (Post) 
activation of Akt (arbitrary units) in aged horses receiving concentrates with no 
amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) 
A1 
 
 
B2 
 
CON, n=6; LYS/THR and LYS/THR/MET post, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
For the LYS/THR/MET treatment post time point n=5. One horse’s data was omitted due to injury and 
inability to collect sample. 
1Representative western blots of phosphorylated (P) and total (T) forms of Akt 
2Least squares mean ± pooled standard error expression of phosphorylated form of Akt in gluteal muscle 
samples taken in the pre-feeding state (white bars) and the post-feeding state (black bars). Expression of the 
phosphorylated form of Akt was expressed relative to total expression, and the values for pre-feeding CON 
horses were expressed as an arbitrary value of 1.0. 
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Figure 5.8 Before the morning meal (Pre) and after the morning meal (Post) 
activation of rpS6 (arbitrary units) in aged horses receiving concentrates with no 
amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) 
A1 
 
B2 
 
CON, n=6; LYS/THR and LYS/THR/MET post, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
For the LYS/THR/MET treatment post time point n=5. One horse’s data was omitted due to injury and 
inability to collect sample. 
1Representative western blots of phosphorylated (P) and total (T) forms of rpS6 
2Least squares mean ± pooled standard error expression of phosphorylated form of rpS6 in gluteal muscle 
samples taken in the pre-feeding state (white bars) and the post-feeding state (black bars). Expression of the 
phosphorylated form of rpS6 was expressed relative to total expression, and the values for pre-feeding 
CON horses were expressed as an arbitrary value of 1.0. 
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Atrogin-1 
Atrogin-1 is a protein associated with muscle protein degradation. There was no 
significant effect of treatment or time on Atrogin-1 activation (P>0.05; Figure 5.9), 
however, there was a significant (P=0.035; Figure 5.9) treatment by time interaction, 
where post-feeding CON activation tended to be lower than pre-feeding CON activation 
(P=0.068). There was no significant effect of period (P=0.50) or period by time 
interaction (P=0.20) on Atrogin-1 abundance.  
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Figure 5.9 Before the morning meal (Pre) and after the morning meal (Post) relative 
abundances of Atrogin-1 (arbitrary units) in aged horses receiving concentrates 
with no amino acid supplementation (CON), lysine and threonine supplementation 
(LYS/THR) or lysine, threonine and methionine supplementation (LYS/THR/MET) 
A1  
 
B2 
 
 
CON, n=6; LYS/THR and LYS/THR/MET post, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
For the LYS/THR/MET treatment post time point n=5. One horse’s data was omitted due to injury and 
inability to collect sample. 
1Representative western blots of Atrogin-1 and α-Tubulin  
2Least squares mean ± pooled standard error expression of Atrogin-1 in gluteal muscle samples taken in the 
pre-feeding state (white bars) and the post-feeding state (black bars). Expression of Atrogin-1 was 
expressed relative to α-Tubulin, a control for total protein expression, and the values for pre-feeding CON 
horses were expressed as an arbitrary value of 1.0. 
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 AMPK 
AMPK is a protein associated with inhibition of protein synthesis signaling There 
was no significant effect of treatment or time (P>0.05; Figure 5.10) on AMPK activation. 
However, there was a significant effect of period (P=0.040; Figure 5.10) on AMPK 
activation, where AMPK activation appears to increase, although not significantly 
(P>0.05), from collection period one to six. Additionally, there tended to be a significant 
treatment by time interaction (P=0.069), where the CON treatment and LYS/THR/MET 
treatment had slightly, but not significantly, higher post-feeding values of AMPK 
activation, but the LYS/THR treatment had slightly, but not significantly, higher (P>0.05) 
pre-feeding values of AMPK activation. Finally, there tended to be a significant period 
by time interaction (P=0.066) on AMPK activation, where period one and two had 
similar pre- and post-fed levels of AMPK activation, period three and four had slightly, 
but not significantly, lower (P>0.05) pre-feeding levels of AMPK activation, and period 
five and six had slightly, but not significantly, higher (P>0.05) pre- feeding values 
compared to post-feeding AMPK activation. 
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Figure 5.10 Before the morning meal (Pre) and after the morning meal (Post) 
relative abundances of AMPK (arbitrary units) in aged horses receiving 
concentrates with no amino acid supplementation (CON), lysine and threonine 
supplementation (LYS/THR) or lysine, threonine and methionine supplementation 
(LYS/THR/MET) 
A1  
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Figure 5.10 Continued 
C: AMPK by Period 
 
CON, n=6; LYS/THR and LYS/THR/MET post, n=5. For the LYS/THR treatment one horse’s data was 
omitted due to a systemic infection.  
For the LYS/THR/MET treatment post time point n=5. One horse’s data was omitted due to injury and 
inability to collect sample. 
1Representative western blots of phosphorylated (P) and total (T) forms of AMPK 
2Least squares mean ± pooled standard error expression of phosphorylated form of AMPK in gluteal 
muscle samples taken in the pre-feeding state (white bars) and the post-feeding state (black bars). 
Expression of the phosphorylated form of AMPK was expressed relative to total expression, and the values 
for pre-feeding CON horses were expressed as an arbitrary value of 1.0. 
3Period 1, 2, 3, 5 and 6, n = 3; Period 4, n=2. For the period 4 n=2. One horse’s data was omitted due to a 
systemic infection 
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Chapter 6. Discussion 
Crude Protein Intake 
 Although the treatments in this study were designed to meet or slightly exceed 
recommended nutrient intakes for mature horses at maintenance, an unexpectedly high 
crude protein and digestible energy content of the hay cubes led to a higher crude protein 
and digestible energy intake than was expected. There was approximately a 5.5 Mcal 
digestible energy, and a 670 g excess crude protein intake (for a 500 kg horse) per day. 
Because of this, it is likely that the horses on the CON treatment were already consuming 
more amino acids than they required, and it is not likely that further supplementation with 
amino acids above the CON intakes would have shown improvements in whole-body or 
muscle protein metabolism. 
 
Body Weight 
 The significant effect of treatment on body weight suggests that horses receiving 
the LYS/THR/MET treatment gained more weight over the course of the period than 
horses receiving the LYS/THR treatment. However, there was also a significant effect of 
period on body weight, where horses seemed to gain an appreciable amount of weight 
over their first experimental period (periods 1 and 4), and then lose weight during their 
second experimental period (periods 2 and 5). Since horses were kept on pasture prior to 
being enrolled in our experiment, there was a large difference in diet composition 
between their previous diets and the adaptation and experimental treatments. Thus, it 
seems that horses may have been experiencing changes in body weight in response to 
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changes in diet during the first experimental period. This would suggest that the 2 weeks 
of adaptation to housing and diets prior to the beginning of experimental procedures was 
not a sufficient amount of time for the horses to adapt. Additionally, differences in weight 
gain between treatments are likely due to natural variation in adaptation and weight gain, 
rather than a true effect of treatment. 
  
Plasma Glucose, Insulin, Urea Nitrogen and Creatinine Concentrations 
Peak glucose concentrations occurred at approximately 60 minutes after feeding 
and peak insulin concentrations occurred at approximately 120 minutes after feeding, 
suggesting that horses were in a fed state approximately 60 minutes after consuming a 
meal. Similar plasma glucose and insulin concentrations in response to meal feeding 
suggest a similar glycemic and insulinemic responses between treatments. Horses had the 
expected post-prandial glycemic and insulinemic responses, and glucose and insulin 
concentrations were within normal ranges, and similar to previously reported data 
(Ralston et al., 1988; Stull and Rodiek, 1988). 
No significant difference in PUN concentrations over time suggests that 
circulating PUN concentrations were not influenced by feeding a meal. There was a 
significant effect of period, where PUN concentrations were significantly higher for 
periods 1-3 than for 4-6. This difference is likely due to the fact that periods 1-3 used 
geldings, and periods 4-6 used mares. PUN concentrations have been shown to be 
significantly affected by sex in other species such as pigs, where PUN concentrations 
were higher for barrows than for gilts at 149 days of age, although the same patterns of 
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PUN concentrations and sex were not observed at 107 and 128 days of age (Klindt et al., 
2006).  
PUN concentrations (CON=4.75; LYS/THR=5.11; LYS/THR/MET=5.21 
mmol/L; P<0.0001) were similar to values previously reported in aged horses, where 
concentrations were higher for horses not supplemented with amino acids (7.44±0.31 
mmol/L) than horses supplemented with lysine and threonine (5.59±0.31 
mmol/L)(Graham-Thiers and Kronfeld, 2005). Additionally, the concentrations were 
slightly higher than concentrations observed in foals and yearlings that were either fed a 
basal diet that was 14% crude protein (PUN=3.12±0.06 mmol/L) or fed a lower protein 
(CP=8.5%) diet supplemented with lysine and threonine (PUN=3.13±0.06 mmol/L), in a 
study that also showed no effect of supplementation on PUN concentrations (Staniar et 
al., 2001). It is worth noting that both in the present study and in the study of weanlings 
and yearlings (Staniar et al., 2001), where there was no significant effect of 
supplementation on PUN concentrations, animals were not regularly exercised, whereas 
in the previous study that did observe treatment related differences in PUN 
concentrations (Graham-Thiers and Kronfeld, 2005), horses were in an exercise program. 
It is likely that in the sedentary horses in the present study, amino acid requirements were 
met by the basal diet, as the crude protein intake for the CON treatment was higher than 
what is currently recommended (NRC, 2007). In the previous study the crude protein 
intakes were likely closer to the actual requirement, because of a combination of lower 
crude protein intake and exercise. Therefore, it is reasonable to have observed differences 
in PUN concentrations between treatments in the previous study.  
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Significant effects of treatment on PUN concentrations suggest that there are 
differences in dietary amino acid use between treatments. PUN concentrations in horses 
receiving amino acid supplementation, LYS/THR and LYS/THR/MET, relative to CON 
suggest a greater catabolism of absorbed dietary amino acids.  This could indicate that the 
supplemented amino acids were not contributing to additional protein synthesis, but were 
instead being catabolized. This similar degree of catabolism of supplemented dietary 
amino acids suggests that neither lysine, threonine, nor methionine were limiting amino 
acids in the CON diet.  Diets were formulated to be isonitrogenous, and nitrogen intakes 
were therefore similar across all treatments, despite the supplementation of amino acids. 
However, the additional amino acids in the CON diet were protein-bound, as the CON 
diet was kept isonitrogenous by altering the contributions of wheat middlings and 
soybean hulls (Table 4.3). Therefore, if digestion of the protein-containing fractions was 
not complete in the small intestine, the additional amino acids in the CON treatment may 
not have been available for absorption as in the supplemented treatments, resulting in less 
absorption of amino acids, and therefore less catabolism as evidenced by PUN 
concentrations. However, it is worth noting that nitrogen absorption as calculated from 
the difference between intake and fecal excretion did not show significant differences 
between treatments (Table 5.2). However, it is also important to note that the reported 
values for nitrogen absorption are only an estimate based on intake and excretion, not a 
direct measurement of absorption, and therefore may not have been sensitive enough to 
identify small differences in nitrogen excretion as may have been caused by fecal 
excretion of the relatively small amounts of supplemented free amino acids.  
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There were no significant effects of treatment on plasma creatinine 
concentrations, which suggests that there were not significant differences in muscle mass 
between treatments. The observed plasma creatinine concentrations were similar to those 
published in previous studies of aged horses (Graham-Thiers and Kronfeld, 2005). While 
some studies have shown increases in plasma creatinine concentrations in response to 
supplementation of specific amino acids (Graham-Thiers and Kronfeld, 2005; da Costa 
Cordeiro Manso et al., 2015), the same improvement in plasma creatinine concentration 
was not observed in this study. This result could be due to the fact that 15 days of 
adaptation to a diet without the influence of exercise might not be a sufficient amount of 
time to induce significant changes in muscle mass, as other studies have used between 30 
days (da Costa Cordeiro Manso et al., 2015) and 14 weeks (Graham-Thiers and Kronfeld, 
2005) of adaptation to diet before re-assessing creatinine levels. However, when taken 
together with lack of significant differences in whole-body phenylalanine kinetics and 
nitrogen balance, the data suggests that the supplementation of lysine and threonine, or 
lysine, threonine and methionine did not positively alter amino acid metabolism and 
protein synthesis, and it is therefore unlikely that there would have been significant 
changes in muscle mass if given a longer adaptation time. Additionally, in previous 
studies showing significant improvements in plasma creatinine concentrations, horses 
were in a regular exercise program, in addition to receiving amino acid supplementation 
(Graham-Thiers and Kronfeld, 2005; da Costa Cordeiro Manso et al., 2015). Therefore, 
improvements in muscle mass as indicated by plasma creatinine concentrations may have 
been due to a combination of amino acid supplementation and exercise, rather than amino 
acid supplementation alone.  
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It is interesting to note that there tended to be an effect of period, and that period 5 
had higher plasma creatinine concentrations compared to other periods. However, there 
was not a significant difference of any other variable measured for period five, including 
urinary creatinine output, which was not significantly different from periods one, two, or 
four. Therefore, the cause of the high plasma creatinine concentration in period five is 
unknown.   
 
Plasma Amino Acid Concentrations 
In the present study, all measured plasma amino acid concentrations except 
glutamate, glycine and tryptophan were significantly affected by time, and increased after 
feeding a meal. This confirms that dietary amino acids were being absorbed during the 
time of blood sampling. These results are similar to a previous study examining the 
effects of threonine supplementation on plasma metabolite concentrations in growing and 
mature horses, where all amino acid concentrations except glutamate, tryptophan and 
aspartate were higher 90 minutes after feeding a meal compared to the pre-feeding 
baseline (Mastellar et al., 2016b). These results are in contrast to a previous study 
examining the effects of pituitary pars intermedia dysfunction on whole-body 
phenylalanine kinetics and skeletal muscle protein signaling in aged horses, where there 
was no observed increase in plasma amino acid concentrations 90 minutes after feeding a 
meal, despite increases in plasma glucose and insulin concentrations, suggesting that 
horses were in a postprandial state (Mastro et al., 2014).  The differences observed 
between studies likely result from the fact that the aforementioned previous studies only 
analyzed samples taken directly before feeding, and 90 minutes after consuming a meal, 
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whereas the present study examined samples every 30 minutes from 30 minutes before 
feeding a meal to 240 minutes after feeding a meal. Because of the small window of time 
in which samples in the previous studies were taken, small differences in rates of 
digestion and absorption or metabolism of amino acids could account for the differences 
seen. However, it should be noted that in the present study, the plasma amino acid 
concentrations of the 90 minute samples were significantly higher than plasma amino 
acid concentrations of both the -30 min and the 0 min baseline samples (P<0.05; Table 
5.1) for all of the amino acids that showed a significant effect of time on plasma amino 
acid concentration. Additionally, horses in the present study were consuming 
approximately twice the recommended protein intake, which could have led to larger 
post-feeding changes in plasma amino acid concentrations than were observed in the 
previous studies. 
As expected, plasma lysine and threonine concentrations were significantly higher 
in horses receiving LYS/THR and LYS/THR/MET than when horses received the CON 
treatment. Lysine and threonine concentrations peaked at approximately 60 minutes, 
similar to glucose and insulin concentrations. Plasma concentrations of methionine 
peaked between 90 and 120 minutes, and as expected, the supplementation of methionine 
resulted in significantly higher plasma methionine concentrations. However, it is 
interesting to note that supplementation of lysine and threonine also resulted in higher 
plasma methionine concentrations when compared to CON. Elevated methionine 
concentrations in response to threonine supplementation have been previously 
documented in horses, and have been suggested to result from negative feedback of 
threonine degradation (Mastellar et al., 2016b). Since threonine degradation (Dale, 1978) 
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and methionine degradation (Finkelstein, 1990) can both lead to the production of α-
ketobutyrate, it is possible that increases in threonine degradation of the supplemented 
threonine produced α-ketobutyrate, which fed back to inhibit the degradation of 
methionine, and resulted in increased plasma methionine concentrations. Conversely, 
there was a small amount of DL – Methionine added to the LYS/THR concentrate to 
maintain similar methionine levels between treatments as the ratios of soybean hulls and 
wheat middlings were altered (Table 4.3). Since the DL – Methionine added was in the 
form of crystalline amino acid, it is possible that it was absorbed more readily than the 
methionine in the CON treatment, leading to increased methionine concentrations 
compared to the CON treatment. Furthermore, it is interesting that methionine 
concentrations peaked approximately 30 minutes later than lysine and threonine 
concentrations, suggesting either a delay in digestion or absorption of methionine.   
In addition to significant differences in plasma concentrations of the 
supplemented amino acids, there was a significant effect of treatment on the plasma 
concentrations of glutamate, leucine, phenylalanine and serine. Glutamate was 
significantly higher for CON than for LYS/THR (22.7 mmol/L; P=0.0379) and tended to 
be higher for CON than for LYS/THR/MET (16.7 mmol/L; P=0.094). Differences in 
plasma glutamate concentrations likely resulted from differences in metabolism of other 
amino acids. Glutamate is a common acceptor of ammonia in nitrogen sparing reactions, 
and is the preferred nitrogen donor in many transamination reactions (Mourtzakis and 
Graham, 2002). Therefore, the higher glutamate concentrations for CON suggest that 
more amino acids were being transaminated to glutamate as a result of excess dietary 
amino acid intake, to spare nitrogen that would be lost during amino acid catabolism and 
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excretion. This increase in nitrogen sparing could be responsible for the decreased plasma 
urea concentrations observed in CON as compared to LYS/THR and LYS/THR/MET. 
Conversely, higher plasma glutamate concentrations could be owing to the fact that 
glutamate/glutamine concentrations were slightly higher for the CON concentrate 
(1.58%) than for the LYS/THR (1.43%) and LYS/THR/MET (1.35%) concentrates 
(Table 4.2). However, it is unlikely that these small differences in intake could have 
accounted for the differences in plasma glutamate observed. 
Serine concentrations were significantly higher for LYS/THR than for 
LYS/THR/MET, and glycine concentrations tended to be affected by the treatment*time 
interaction, where glycine concentrations peaked earlier and more sharply for LYS/THR 
and LYS/THR/MET than for CON. Differences between treatments likely arise because 
threonine, glycine and serine metabolism are closely linked. In order to enter the citric 
acid cycle, hydrocarbons from threonine and glycine are converted to serine. Therefore, 
increases in glycine, serine and PUN concentrations for LYS/THR and LYS/THR/MET 
suggest that the supplemented threonine was being catabolized. Increasing dietary 
threonine intake has been shown to increase concentrations of serine and glycine in swine 
(Edmonds and Baker, 1987), and to increase glycine concentrations in horses (Mastellar 
et al., 2016b).  
 
Nitrogen Metabolism and Urinary Creatinine Output 
The lack of significant differences in nitrogen balance between treatments further 
supports the conclusion that there were no significant improvements in whole body 
nitrogen metabolism when potentially limiting amino acids were supplemented in the diet 
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of aged horses. Furthermore, the consistently slightly negative nitrogen balance suggests 
a net loss of nitrogen, and therefore of body protein. Negative nitrogen balance could be 
indicative of a net loss of skeletal muscle protein, and therefore muscle mass, which 
could be indicative of muscle wasting, as is the case for aged animals experiencing 
sarcopenia. In humans, increased proportions of non-muscle protein in the body, namely 
visceral tissue, which is known to have a relatively high protein turnover rate, have been 
linked to higher protein intakes required to maintain nitrogen balance, and authors 
suggest that higher protein intakes may minimize sarcopenia (Morais et al., 2006).  
Alternatively, a negative nitrogen balance could be an indicator of the stress of 
confinement and collection procedures, as negative nitrogen balance has been observed in 
response to emotional anxiety in humans (Scrimsha, et al., 1966). The observed tendency 
toward decrease in nitrogen intake and absorption on d 10 were possibly due to the acute 
stress of confinement and collection procedures. However, these fluctuations in intake 
and absorption did not result in significant differences in any of the nitrogen retention 
parameters, suggesting either that on d 10 the animals had a slightly, but not significantly, 
lower urinary nitrogen output, or that the differences in intake and absorption were 
statistically, but not physiologically significant.  
Similar to plasma creatinine concentrations, there were no significant differences 
in urinary creatinine output between treatments, further supporting the conclusion that 
there was not a significant difference in muscle mass between treatments after 10 days of 
supplementation with lysine and threonine or lysine, threonine and methionine. However, 
there was a significant effect of period on urinary creatinine output, where the first two 
collection periods for each set of horses had significantly higher creatinine outputs than 
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the last period for each set of horses, and there was a significant effect of day of 
collection, where the last day of collection showed lower urinary creatinine output than 
the first two days of collection. In essence, it appears that urinary creatinine output 
decreased consistently both within and between collection periods as time progressed for 
both groups of horses. The most likely cause of this change is a decrease in stress as 
animals adapted to stress related to wearing collection harnesses. It has been well 
documented in humans that feelings of restlessness, apprehension or anger exhibit 
increased urinary creatinine output (Schottstaedt et al., 1956; Price, 1971). Although 
horses were exposed to collection harnesses before beginning experimental procedures, 
changes in daily routine such as restriction to the stall during total urine and feces 
collection and the collection of urine and feces every 4 h for 72 h may have caused 
emotional distress, and therefore increased urinary creatinine output.  Increased urinary 
creatinine output during stress has been attributed to increased glomerular filtration 
during times of emotional diuresis in some instances (Miles et al., 1952). However, there 
was no evidence of emotional diuresis in the present study, as urine output was not 
significantly different between days of collection (P=0.7261) or collection period 
(P=0.7307). 
 
Phenylalanine Kinetics 
Non-oxidative phenylalanine disposal (use for protein synthesis) was consistently 
lower than rates of phenylalanine release from protein breakdown, which is in agreement 
with the consistently negative nitrogen balance data. Together, the data indicate that 
regardless of supplementation with lysine and threonine or lysine, threonine and 
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methionine, the aged horses in the present study were degrading protein at a greater rate 
than they were accreting it, which suggest a net loss of body protein. Although the horses 
in the present study were aged, it is important to note that they were not clinically 
diagnosed with sarcopenia. However, the imbalances in nitrogen retention and 
phenylalanine kinetics data suggest that there was an imbalance in protein synthesis and 
degradation similar to that which is observed during sarcopenia. Additionally, if the 
protein being degraded was primarily skeletal muscle, this imbalance could have been 
contributing to the loss of muscle mass and function characteristic of sarcopenia. 
Conversely, the loss of body protein could have been owing to high endogenous losses of 
protein, or breakdown and loss of protein from tissues other than muscle. Taking together 
the lack of significant differences in creatinine, phenylalanine kinetics and nitrogen 
balance, the data suggests that there was no change in whole-body protein synthesis or 
skeletal muscle accretion with supplementation of lysine and threonine or lysine, 
threonine and methionine, but that horses had a net loss of body protein regardless of 
diet.  
  Phenylalanine flux (approximately 60 ± 3 µmol/kg/h; Table 5.4) in the present 
study was similar to values observed in mature horses (approximately 60 ± 3 µmol/kg/h) 
observed in a previous study (Mok, 2015).  However, phenylalanine released from 
protein breakdown (approximately 35 µmol/kg/h) in the previous study (Mok, 2015) was 
considerably lower that what was observed in the aged horses in the present study 
(approximately 50 ± 3 µmol/kg/h; Table 5.4). Furthermore, rates of non-oxidative 
phenylalanine disposal (approximately 45 µmol/kg/h) in the previous study (Mok, 2015) 
was similar to those observed in the present study (approximately 40±3 µmol/kg/h; Table 
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5.4). Together, these data suggest that the aged horses in the current study were 
experiencing higher rates of protein degradation and lower rates of protein synthesis than 
the previously observed mature horses. 
In comparing the balance between non-oxidative phenylalanine disposal and 
phenylalanine released from protein breakdown to previous literature in horses of 
different ages, there are a number of interesting differences. In the present study, 
phenylalanine released from protein breakdown was higher than non-oxidative 
phenylalanine disposal, which suggests that rates of protein breakdown were higher than 
rates of protein synthesis. These results are in contrast to previous studies, where growing 
horses (Tanner et al., 2014; Mastellar et al., 2016b) and mature horses (Urschel et al., 
2012; Mastellar et al., 2016b) exhibit higher rates of non-oxidative disposal than 
phenylalanine released from protein breakdown. For the growing horses observed in 
previous studies (Tanner et al., 2014; Mastellar et al., 2016b), a higher flux coupled with 
higher non-oxidative phenylalanine disposal compared to the previous data observed in 
mature and aged horses (Urschel et al., 2012; Wagner et al., 2013; Mastellar et al., 
2016b) suggests that there were higher rates of both protein turnover and accretion in 
growing horses, which is characteristic of muscle deposition. For the mature horses 
previously studied (Urschel et al., 2012; Wagner et al., 2013; Mastellar et al., 2016b), 
lower rates of flux and non-oxidative disposal compared to the growing horses (Tanner et 
al., 2014; Mastellar et al., 2016b) suggests that mature horses were in a steadier protein 
metabolic state, rather than accreting muscle. Similar to the present study, a previous 
study in aged horses (Wagner et al., 2013) showed higher rates of phenylalanine released 
from protein breakdown compared with rates of non-oxidative phenylalanine disposal, 
106 
 
suggesting that the aged horses in the present study, as well as the previous study, may 
have been experiencing tissue protein loss.     
 
Muscle Protein Synthesis and Degradation Signaling  
Akt is an upstream effector, and rpS6 is a downstream effector of mTOR, and 
both are proteins which when activated, stimulate protein synthesis signaling in the 
mTOR pathway.  The significant increase in rpS6 activation in response to meal feeding 
suggests that consuming a meal lead to increased protein synthesis as signaled by rpS6, 
but lack of effect of meal feeding on Akt suggests that the increase in activation was 
brought about by an upstream effector other than Akt. There are a number of upstream 
effectors other than Akt that could been responsible, including mitogen activated protein 
kinase kinase kinase kinase-3 (MAP4K3) or human vacuolar protein sorting 34 (hVps34), 
two proteins that can be activated by presence of amino acids (Drummond et al., 2009). 
However, these results are in contrast to a previous study of the effect of meal feeding on 
mTOR protein signaling in horses, which saw significant increases in rpS6 and Akt 
activation 90 minutes after consuming a meal compared to a post-absorptive state 
(Wagner and Urschel, 2012). Lack of feed withholding in this study likely accounts for 
the differences in our results. Since there was an approximately 18-hour window between 
the evening and morning meal, animals often took several hours, or even all night to 
finish their hay cube ration, therefore it is possible that horses had access to small 
amounts of food up to 2 hours before the beginning of pre-feeding biopsy procedures. 
Additionally, in the previous study (Wagner and Urschel, 2012), insulin concentrations 
from samples taken in a post-absorptive state were between 0 and 5 mIU/L, whereas 
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insulin concentrations of samples taken before morning feeding in the present study were 
approximately 10 mIU/L. Since insulin is an upstream stimulator of Akt activity, we 
expected that increases in plasma insulin concentrations after feeding would have 
stimulated increased Akt phosphorylation. However, there was likely not a large 
difference in activation between pre-feeding samples and post-feeding samples in the 
present study because pre-feeding insulin concentrations in the present study were not as 
low as those observed in previous studies. 
The lack of significant effect of treatment on rpS6 and Akt activation suggest that 
stimulatory proteins in the mTOR pathway are not significantly affected by 
supplementation of lysine and threonine or lysine, threonine and methionine. This is in 
contrast to studies in other species that have examined the effects of other amino acids on 
rpS6 activation. Whey protein in humans after resistance exercise (Wang et al., 2015), 
and leucine and histidine in cell cultures of bovine mammary tissue (Gao et al., 2015) 
have been shown to increase the activation of rpS6 over the control treatments. 
Therefore, the current study does not support the idea that supplementation of lysine and 
threonine or lysine, threonine and methionine increases protein synthesis as signaled 
through Akt or rpS6. 
Atrogin-1 is a protein associated with muscle protein degradation. There was a 
significant treatment by time interaction on Atrogin-1, where the post-feeding CON 
activation tended to be lower than pre-feeding CON activation. However, there was no 
significant difference in pre- feeding and post-feeding activation for the supplemented 
treatments. Some previous studies have shown an improvement in Atrogin-1 signaling 
when amounts of limiting amino acid are increased in the diet (Tesseraud et al., 2009; 
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Wen et al., 2014). The decreased activation of Atrogin-1 when animals were in a pre-
feeding state during amino acid supplementation suggests that supplementation with 
lysine and threonine, as well as lysine, threonine and methionine may have decreased 
signaling associated with muscle protein degradation while horses were in a post-
absorptive state.  
AMPK is a protein associated with the inhibition of protein synthesis signaling, 
and its activation is related to unfavorable cellular energy status. Lack of significant 
differences in AMPK activation between treatments suggests that lysine and threonine or 
lysine, threonine and methionine supplementation did not decrease signals that inhibit 
protein synthesis through AMPK. This is in contrast to research on the effects of other 
amino acids, such as leucine, which when supplemented has been shown to decrease the 
activation of AMPK in rats (Ribeiro et al., 2015). We did see a trend toward a treatment 
by time interaction for AMPK activation. The CON treatment and LYS/THR/MET 
treatment had slightly, but not significantly, higher post-feeding values of AMPK 
activation, but the LYS/THR treatment had a slightly, but not significantly, higher pre-
feeding value of AMPK activation. The differences in pre- versus post-feeding responses 
may arise from the fact that differences in AMPK activation typically arise from a 
negative cellular energy balance, and since horses were likely never in a truly fasted state, 
differences in AMPK activation likely reflect natural variations between horses, rather 
than true effects of fasting. Additionally, there was a significant effect of period, where 
AMPK activation appears to increase, although not significantly, from collection period 
one to six. Since periods one through three and four through six were different groups of 
horses, that would also suggest that AMPK activation was slightly, but not significantly 
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higher for horses in periods four through six. Since AMPK is activated in response to 
negative cellular energy balance (Viollet et al., 2009), this would suggest that horses were 
in an increasingly declining cellular energy status as they progressed through periods of 
collection. However, it is important to note that while there was a significant main effect 
of period, separation of means showed no significant differences between periods, and 
the observed differences may therefore also be due to natural variations in AMPK 
abundance and activation between horses.  
Taking all of the signaling data from the present study together, it appears that for 
the proteins in the pathways measured there was not an increase in stimulatory signaling 
of protein synthesis, or a decrease in signaling for proteins that inhibit protein synthesis 
when lysine and threonine or lysine, threonine and methionine were supplemented. There 
was an improvement in signaling for a protein that stimulates protein breakdown when 
amino acids were supplemented. The lack of significant effect of treatment on most 
measures of skeletal muscle signaling was mirrored by no significant improvements in 
phenylalanine kinetics or nitrogen balance between treatments.  
 
Comparison of the Present Study to Previous Equine Research 
The levels of lysine and threonine supplementation in the present study were 
selected based on those used by Graham-Thiers and Kronfeld (Graham-Thiers and 
Kronfeld, 2005), which resulted in improvement of certain measures of muscle mass in 
aged horses. In the present study, supplementation with lysine and threonine or lysine, 
threonine and methionine did not improve the balance between muscle protein accretion 
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and degradation in old horses. Comparing the current study to the previous study that 
showed significant improvements in PUN, 3MH, creatinine and subjective muscle mass 
scores in aged horses (Graham-Thiers and Kronfeld, 2005) with supplementation of 
lysine and threonine, there are several factors that could account for the different 
outcomes.  
First, the forage used in the current study had a higher crude protein (11.1%), 
lysine (0.43%), threonine (0.38%) and methionine (0.22%) content than the forage used 
in the previous study (crude protein=9%; lysine= 0.23%; threonine= 0.24%; methionine= 
0.09%).  Because forage formed the majority of the diet used in both studies, it is likely 
that the horses in the present study were consuming a better quality diet with respect to 
protein before additional supplementation of amino acids, and crude protein intakes for 
the control treatment for the horses in the previous study were lower (approximately 2.3 
g/kg BW/d) than in the present study (approximately 2.6 g/kg BW/d). Additionally, 
lysine intakes were considerably lower for control horses in the previous study 
(approximately 69 mg/kg BW/d) than in the present study (approximately 100 mg/kg 
BW/d). However, it is interesting to note that the recommended lysine intake as a 
percentage of crude protein intake (4.3% CP as lysine; NRC, 2007) was not met by the 
control diet in the present study (approximately 3.9% CP intake as lysine) or by the 
control diet in the previous study (approximately 3.0% CP intake as lysine). However, 
data suggests that lysine and threonine may have been limiting protein synthesis in the 
study conducted in 2005 (Graham-Thiers and Kronfeld, 2005), but that the requirements 
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may have been met by the CON diet in the present study, resulting in lack of significant 
differences with additional supplementation.  
Second, in the previous study, the treatments were not isonitrogenous (Graham-
Thiers and Kronfeld, 2005), whereas the diets in the current study were isonitrogenous. 
Therefore, improvements in the measures of protein metabolism in the previous study 
may have resulted from increased nitrogen intake, rather than a better balance of amino 
acids.  
Additionally, the horses in the previous study (Graham-Thiers and Kronfeld, 
2005) were used in a college riding program throughout the study, whereas the horses in 
the current study were sedentary.  Many studies show improvements in markers of 
protein metabolism in aged individuals that are both exercising and receiving amino acid 
supplementation (Graham-Thiers and Kronfeld, 2005; Montoro et al., 2015; Phillips, 
2015; Trabal et al., 2015). It is possible that in the previous studies, the combination of 
protein or amino acid supplementation and anabolic effects of exercise combined could 
be responsible for the significant improvements observed. Conversely, since exercising 
increases the estimated protein requirement (NRC, 2007), it is possible that the horses in 
the previous study simply had higher protein requirements than the sedentary horses in 
the present study, and the control treatment in the previous study was therefore closer to 
meeting, rather than exceeding the required amount of protein intake. Therefore, while 
exercise may have necessitated additional amino acids in previous studies, the sedentary 
horses in the present study may not have required additional amino acids. 
 Finally, it horses in the previous study were fed experimental treatments for a 
total of 14 weeks, whereas horses in the present study were only fed each experimental 
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treatment for a total of 15 days. It is possible that the length of time needed to see 
significant improvements in protein metabolism in response to lysine and threonine, or 
lysine, threonine and methionine metabolism is longer than 15 days. 
 
Limitations and Avenues of Further Research 
 There are a number of aspects of the current experiment that could be improved 
upon, and there are many avenues of research that could be pursued in light of results of 
the current study.  
In the present study, it was postulated that one of the reasons we measured no 
significant differences, despite the fact that a similar previous study did (Graham-Thiers 
and Kronfeld, 2005), was that the hay cubes that we used were of a high enough protein 
quality to exceed horses’ protein and amino acid requirements when fed in combination 
with the CON concentrate. The hay cubes used in the current study were 11.1% crude 
protein, which is similar to the average estimate for mature cool-season grass hay 
provided by the NRC (10.8%) and, the lysine concentration of our hay cubes was 0.43%, 
which is also similar to the estimate for mature cool -season grass (0.38%) published in 
the NRC (NRC, 2007).  However, the hay cubes were fed at a rate of 1.8% of body 
weight per day, and the concentrates were fed at a rate of 0.5% of body weight per day, 
summing to a total daily intake of 2.3% of body weight per day. It may have been 
prudent to feed hay at a rate of 1.5% of body weight per day instead of 1.8% of body 
weight per day, because feeding at a lower percentage of body weight would decrease 
crude protein and lysine intakes, and thus supplementation of individual limiting amino 
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acids may improve markers of whole body and muscle protein metabolism.  If that is the 
case, rations could be formulated with hay fed at a slightly lower percentage of body 
weight, which could be more cost effective, and may also be helpful for horses that do 
not readily consume feed at higher percentages of body weight.  
 With respect to nitrogen balance and urinary creatinine output data, there is some 
evidence to support the idea that there were acute effects of stress on the animals studied 
as a result of confinement and/or collection procedures. Indicators of acute stress 
included consistently negative nitrogen balance data, significantly lower nitrogen intake 
on the first day of collection, and decreasing urinary creatinine output throughout the 
three-day collection period. In light of these changes, a longer urine and feces collection 
procedure may have offered the animals a chance to better adapt to collection procedures, 
and also may have allowed for more accurate measurement of normal fluctuations in 
nitrogen and creatinine output. 
 With respect to improvements in the design of this experiment, inclusion of 
exercise as a factor in the experiment may have shown more significant differences in 
nitrogen balance and phenylalanine kinetics, as exercise has been shown to improve 
nitrogen retention (Campbell et al., 1995) and whole body protein metabolism (Sheffield-
Moore et al., 2004; Short et al., 2004) in humans. Additionally, exercise may cause 
additional nitrogen losses from sweating, increased muscle turnover, and other factors, 
resulting in a higher demand for essential amino acids. Furthermore, there is an 
abundance of data in humans that suggests that leucine supplementation and exercise 
ameliorate sarcopenia (Bukhari et al., 2015; Trabal et al., 2015; Ispoglou et al., 2016). 
Therefore, inclusion of a leucine-supplemented diet in addition to including an exercise 
114 
 
program may show more significant improvements in measures of whole body and 
muscle protein metabolism in aged horses.  
Conclusion 
Despite the fact that horses in the present study were in a negative nitrogen 
balance and had higher rates of phenylalanine oxidation than non-oxidative phenylalanine 
disposal, the data from the present study indicated no improvements in nitrogen balance, 
phenylalanine kinetics, or muscle mass as indicated by circulating creatinine or creatinine 
output with supplementation of lysine and threonine or lysine, threonine and methionine. 
Furthermore, it suggests that muscle protein synthesis signaling in the aged horses in the 
present study was not improved by supplementation of lysine and threonine or lysine, 
threonine and methionine. This suggests that the net loss of nitrogen as evidenced by 
negative nitrogen balance and higher rates of phenylalanine oxidation than non-oxidative 
phenylalanine disposal in the sedentary horses studied was not owing to limitations in 
lysine and threonine or lysine, threonine and methionine.  
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